rfhg_134713.1

Basic information about the TSS

---

TSS ID: rfhg_134713.1 Species: human Chr: chr11		Start: 17208515 End: 17208545 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS,CTCF-bound (EH38D2428139,EH38E1524547)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000528644.5:-362 GeneID: 4925 HGNC/MGI_ID: HGNC:8044 UniProt_ID: A0A1B0GXJ7 Nearer transcript ids and distances:

Gene_name: PIK3C2A Gene_symbol: NUCB2 Gene_synonyms: NEFA Gene_source: HGNC:8044

TATA-Box annotation

---

Distance to TSS:	-544
Nearest PromoterID:	NM_001321378
Entrez ID:	5286
Nearest Unigene:	Hs.175343
Nearest Refseq:	NM_002645
Nearest Ensembl:	ENSG00000011405
Gene Name:	PIK3C2A
Gene Alias:	CPK|OCSKD|PI3-K-C2(ALPHA)|PI3-K-C2A|PI3K-C2-alpha|PI3K-C2alpha
Gene Type:	protein-coding
CpG%:	0.033333
GC%:	0.419355
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NUCB2 p2@NUCB2 p3@NUCB2 p4@NUCB2 p5@NUCB2 p7@NUCB2 p8@NUCB2 p9@NUCB2
Sample		p1@NUCB2	p2@NUCB2	p3@NUCB2	p4@NUCB2	p5@NUCB2	p7@NUCB2	p8@NUCB2	p9@NUCB2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	20.06	3.70	4.29	3.51	0.00	0.58	0.58	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	16.19	2.23	2.23	0.40	0.00	0.61	0.81	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.61	3.47	3.28	3.67	0.00	1.54	1.74	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	13.51	2.29	3.12	0.42	0.21	0.42	1.04	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.72	2.70	2.92	2.92	0.00	1.12	0.67	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.61	2.33	5.04	4.26	0.00	1.36	1.36	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	21.57	3.92	5.01	3.70	0.22	2.83	1.96	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	15.99	2.42	4.12	3.88	0.24	1.94	0.73	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	16.24	2.14	2.56	0.85	0.00	2.14	0.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	19.71	4.06	2.32	5.22	0.00	1.16	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	15.77	0.40	4.04	2.43	0.00	1.62	1.62	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.20	2.44	4.88	0.41	0.00	0.81	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.41	7.90	4.19	0.16	0.48	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.18	6.92	3.76	0.00	0.45	0.30	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	15.15	8.12	4.39	0.22	0.22	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.06	6.29	5.28	0.25	0.25	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.70	5.46	3.93	0.44	0.22	0.22	1.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.08	8.86	4.22	0.42	0.00	0.84	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.40	2.13	1.07	0.00	1.07	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.08	8.27	4.06	0.90	0.60	0.15	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.69	9.22	4.28	0.80	0.27	0.27	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.12	6.56	3.97	0.17	0.35	0.17	0.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.63	6.33	4.27	0.26	0.13	0.00	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10.43	5.82	4.37	0.24	0.24	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.84	4.39	4.90	0.52	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.08	5.06	4.11	0.95	0.00	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	6.04	3.30	1.65	1.10	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.61	10.84	5.66	0.24	0.71	0.47	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.15	6.62	3.88	0.81	0.65	0.16	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.49	10.68	2.90	0.36	0.36	0.00	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.10	6.70	3.14	0.42	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.82	6.64	4.10	0.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.29	8.86	3.38	0.21	0.00	0.21	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	17.65	7.42	4.29	0.82	0.00	0.49	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11.22	9.16	4.49	0.75	0.37	0.00	0.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.58	8.43	4.22	0.19	0.19	0.38	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.83	9.61	4.91	0.82	0.00	0.20	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.07	6.65	4.84	0.81	0.20	0.00	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.69	9.72	4.05	1.62	0.00	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.56	9.12	2.88	0.72	0.48	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.23	7.29	2.35	0.47	0.47	0.24	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	12.74	6.88	4.10	0.29	0.29	0.29	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.12	8.65	3.16	1.27	0.21	0.42	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.94	6.82	4.20	0.17	0.17	0.17	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.65	7.83	4.02	0.80	0.60	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.10	7.91	3.49	0.93	0.23	0.47	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.08	5.76	4.56	0.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	11.33	6.26	2.68	1.19	0.30	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.73	7.90	4.31	0.48	0.24	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	13.55	6.47	6.07	0.61	0.20	0.40	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.07	6.76	5.94	0.41	1.02	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	18.23	6.45	7.78	0.22	0.00	0.67	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	279.84	181.90	83.95	13.99	0.00	13.99	41.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	13.13	6.74	4.97	0.35	0.71	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	17.89	8.62	6.30	0.66	0.00	0.99	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	63.76	17.62	20.13	2.52	0.84	0.00	7.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	24.34	14.70	10.10	1.38	0.46	0.46	1.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.61	11.02	5.83	0.65	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.56	8.03	8.67	0.64	0.64	0.32	0.96	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	20.75	12.57	9.43	1.57	0.63	0.31	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	12.69	9.87	2.12	0.71	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.65	6.17	4.49	1.12	2.80	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	29.46	19.90	19.11	3.18	0.80	0.00	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.65	7.14	8.83	1.70	0.68	0.00	1.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.60	7.15	8.77	1.30	0.97	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.26	9.23	7.45	0.71	0.71	0.00	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	452.59	113.15	145.48	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	260.62	126.36	110.56	23.69	7.90	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	14.63	7.31	4.39	0.49	0.00	0.00	2.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	19.83	8.43	4.46	1.98	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.52	12.20	6.10	0.00	0.94	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	27.49	19.21	9.27	0.99	0.33	0.99	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	30.62	14.23	7.11	1.24	1.24	0.31	1.86	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	25.68	16.20	6.11	1.22	0.31	0.31	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	23.44	6.34	0.95	0.16	0.32	0.00	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	9.47	6.42	2.25	0.00	0.32	0.48	0.48	0.16
Adipocyte - omental, donor1	11473-119C6	37.53	12.09	4.20	0.38	0.38	0.38	0.51	0.13
Adipocyte - omental, donor2	11474-119C7	17.94	14.20	5.23	0.00	0.00	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	16.75	10.72	2.68	0.33	0.67	0.00	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	20.42	10.85	3.83	0.64	0.64	1.28	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	2.20	2.20	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	33.42	6.77	2.26	0.45	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	2.26	1.56	1.04	0.00	0.17	0.00	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	33.25	28.75	6.85	0.20	1.56	0.20	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	15.19	5.66	2.57	0.00	0.77	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	24.25	12.27	3.07	0.56	0.84	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	12.93	8.23	4.70	0.00	0.59	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	19.22	14.64	4.83	0.24	0.64	0.00	0.16	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	11.62	11.30	3.23	0.00	0.65	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	11.20	4.80	3.73	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	15.02	4.45	11.69	1.11	0.00	0.00	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	7.07	4.99	4.57	0.83	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	8.04	4.52	2.01	0.00	0.25	0.00	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	12.76	5.56	2.95	0.00	0.65	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	6.39	4.26	3.35	0.00	0.30	0.61	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	2.65	2.65	0.00	0.22	0.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	2.40	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	5.40	1.26	0.18	0.00	0.00	0.18	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	1.23	0.62	0.21	0.21	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	16.94	9.04	2.29	0.11	0.23	0.11	0.57	0.00
Anulus Pulposus Cell, donor2	11463-119B5	7.35	7.84	0.98	0.24	0.24	0.00	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.38	8.09	2.25	0.00	0.90	0.00	1.80	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.37	12.16	3.04	0.00	0.43	0.87	1.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	4.28	6.42	0.00	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	18.53	10.76	2.99	0.60	0.00	0.30	1.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	13.91	1.26	0.00	0.00	0.00	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.20	4.62	1.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.00	6.17	2.60	0.32	0.32	0.65	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	13.59	8.74	2.91	0.49	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	10.69	2.38	0.59	1.19	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.21	9.04	3.01	0.38	0.38	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	16.69	13.79	5.08	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	5.02	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	25.20	8.40	2.97	0.82	0.66	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	6.82	2.73	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	18.55	5.13	2.26	0.60	0.30	0.30	0.45	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	12.32	6.43	2.14	0.00	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.74	9.45	3.21	0.19	0.38	0.19	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	14.70	4.81	2.94	0.27	0.00	0.00	1.60	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	4.88	1.95	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.76	9.45	2.99	0.17	0.17	0.33	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	1.20	2.40	0.00	0.00	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	7.08	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	17.50	10.81	3.26	0.86	0.69	0.17	1.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	8.39	8.39	0.00	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.50	7.28	2.43	0.49	0.00	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	22.77	12.14	1.14	0.38	0.38	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	3.63	2.42	0.00	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.97	7.41	3.42	1.71	0.57	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	15.39	6.63	1.50	0.64	0.43	0.43	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.68	4.90	2.84	0.26	0.52	0.00	1.55	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.55	9.38	2.35	0.47	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.93	7.72	2.57	0.00	0.32	0.32	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.13	2.85	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.13	4.09	1.17	0.58	0.58	1.17	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.97	5.12	2.11	0.00	0.00	0.30	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	3.56	4.75	0.00	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.80	13.22	3.05	0.00	0.51	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	15.54	10.19	2.29	1.02	0.00	0.25	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	16.52	3.18	1.27	0.64	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.08	6.47	2.59	0.43	0.86	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	17.15	10.58	3.39	0.21	0.21	0.42	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	12.76	4.35	4.64	0.00	0.29	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.95	11.34	1.89	0.00	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	12.38	7.63	1.86	0.34	0.51	0.17	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	6.34	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.72	10.08	2.79	1.07	0.43	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	6.62	2.41	0.60	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	11.66	6.56	3.64	0.00	0.00	0.00	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.48	10.11	3.22	1.15	0.23	0.23	1.15	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	0.00	5.10	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	19.58	7.88	3.05	0.76	0.00	0.51	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.31	8.88	1.86	0.41	0.00	0.41	0.62	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.85	6.12	1.84	0.31	0.61	0.31	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	18.16	7.17	4.30	1.43	0.48	0.00	1.91	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.75	6.87	2.88	1.55	0.00	1.11	1.11	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	3.05	1.53	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.63	5.54	2.22	0.00	0.55	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.89	9.53	3.44	0.79	0.79	0.26	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.81	5.45	1.82	0.00	0.36	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	4.42	1.84	0.98	0.00	0.25	0.00	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	1.54	2.05	0.17	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	0.00	0.21	0.42	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	11.15	8.02	8.71	0.35	0.70	0.00	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	7.44	6.79	4.21	0.16	0.65	0.00	1.13	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	12.23	11.49	6.86	0.30	0.45	0.30	0.89	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	15.02	10.09	4.01	0.34	0.34	1.38	0.34	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	15.16	8.39	2.63	0.63	0.13	2.38	0.13	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	16.96	8.88	3.64	0.57	0.91	1.82	0.11	0.11
Basophils, donor1	12241-129G9	5.23	2.35	0.26	0.26	0.52	0.26	0.26	0.26
Basophils, donor2	12242-129H1	21.65	7.94	2.16	0.36	0.72	0.00	0.00	0.00
Basophils, donor3	12243-129H2	10.44	6.32	1.32	0.15	0.29	0.29	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	1.08	0.00	0.00	0.00	0.22	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.46	0.91	0.00	0.00	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	2.51	0.63	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	3.95	0.62	0.21	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	7.83	2.07	0.23	0.00	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	10.98	6.84	0.36	0.54	0.18	0.00	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	56.68	14.74	34.63	3.61	1.24	4.02	0.62	1.13
Burkitt's lymphoma cell line:RAJI	10476-106I8	63.12	20.96	25.85	5.82	0.23	0.47	0.23	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	220.96	39.97	186.43	6.40	6.08	10.55	0.32	9.91
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	10.34	206.84	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	6.76	4.51	3.94	0.00	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	9.28	5.01	1.48	0.19	0.37	0.00	0.93	0.00
CD14+ Monocytes, donor3	11381-118B4	6.59	4.17	2.85	0.22	0.44	0.44	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	19.81	14.44	9.62	0.28	0.28	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	31.46	16.30	7.20	0.76	1.14	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	28.60	19.07	8.55	0.33	0.33	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	4.48	2.02	0.87	0.00	0.00	0.00	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	3.92	1.51	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	4.03	1.66	0.71	0.00	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	2.34	1.51	1.34	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.04	2.21	0.00	0.00	0.00	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3.97	1.74	1.24	0.00	0.25	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.70	2.55	0.59	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.56	1.96	0.18	0.00	0.18	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.66	3.70	0.22	0.22	0.22	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.51	3.98	1.17	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.92	4.75	1.58	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	6.66	2.22	1.11	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.46	1.93	0.30	0.00	0.00	0.00	0.30	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.59	2.00	1.20	0.20	0.00	0.00	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	8.33	1.46	1.67	0.21	0.21	0.00	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	4.58	2.29	0.46	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.14	2.49	1.58	0.00	0.23	0.00	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.93	2.62	0.44	0.44	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	2.96	0.54	1.61	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	5.23	3.49	0.70	0.00	0.00	0.00	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.05	1.26	1.26	0.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.51	2.02	1.47	0.18	0.00	0.18	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.17	1.41	0.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	2.19	1.32	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1.74	1.92	0.52	0.00	0.17	0.00	0.70	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.72	4.09	1.12	0.00	0.00	0.00	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6.47	4.10	1.51	0.00	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	0.41	0.82	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.27	2.55	0.23	0.46	0.46	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.41	1.62	0.70	0.46	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	3.92	1.53	0.22	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	2.77	1.39	0.23	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	6.72	3.25	0.22	0.00	0.00	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	8.41	3.43	1.25	0.31	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	9.26	3.84	0.87	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	18.51	5.57	2.01	0.00	0.00	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	3.06	1.02	0.26	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.29	1.10	0.22	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	5.26	2.95	0.63	0.21	0.00	0.00	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	2.03	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	6.10	2.03	4.75	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	2.07	2.07	4.14	0.00	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	4.26	3.20	2.13	0.00	0.53	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	4.82	4.82	5.36	0.00	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4.91	4.21	4.21	0.70	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.92	3.14	6.27	0.00	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	6.59	5.27	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	0.82	0.82	0.82	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	2.18	1.45	1.45	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	2.02	0.50	2.02	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	106.67	39.60	13.74	1.21	2.83	4.44	0.81	4.44
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	72.31	22.77	8.79	1.60	1.20	3.60	0.40	2.80
CD34+ Progenitors, donor1	11545-120B6	57.23	8.03	53.21	3.01	2.01	0.00	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	53.37	7.30	54.50	6.74	1.69	2.81	0.00	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	210.80	48.85	149.55	7.14	7.14	4.88	1.13	6.39
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	230.22	44.42	161.67	11.95	7.89	10.37	0.90	9.24
CD4+ T Cells, donor1	11225-116C1	34.99	15.71	28.56	0.36	1.79	0.00	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	9.19	9.80	3.06	0.00	1.84	0.00	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	12.50	9.45	7.32	0.30	1.83	0.00	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	3.32	2.30	0.26	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	5.84	3.82	1.35	0.45	0.00	0.00	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	5.46	3.74	2.01	0.00	0.29	0.00	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	23.23	8.06	19.91	0.00	1.90	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	33.01	11.24	19.67	1.40	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	13.18	36.26	3.30	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	16.04	5.64	1.16	0.00	0.00	0.14	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	10.68	4.07	0.17	0.68	0.00	0.00	1.02	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	8.54	2.74	0.64	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.07	1.34	0.90	0.45	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	8.39	4.54	0.70	0.35	0.35	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	13.20	7.92	1.76	0.44	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	45.54	8.43	18.97	0.42	0.84	0.00	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	30.96	8.52	8.73	0.42	0.62	0.21	1.66	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.05	6.35	8.69	0.00	1.00	1.00	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	63.63	14.41	68.26	0.27	5.98	0.82	1.90	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	98.08	30.01	91.65	2.68	5.90	0.00	2.14	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	41.24	17.93	59.18	0.00	5.38	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	33.01	9.83	4.26	0.00	0.37	0.56	0.56	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	38.77	13.65	4.12	0.43	0.43	0.87	0.43	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	39.93	15.55	2.73	1.26	0.21	1.47	0.21	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	24.77	10.62	10.11	0.00	1.01	0.51	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	33.79	10.40	3.47	0.00	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	40.09	14.82	13.07	0.00	0.44	0.44	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	53.45	24.25	33.16	0.99	0.49	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	47.08	21.23	30.47	0.00	2.77	1.85	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	44.67	26.52	32.10	0.00	1.40	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	57.88	29.35	43.48	1.11	4.43	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	83.19	27.73	53.99	2.21	4.91	0.98	0.74	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	49.28	16.94	35.42	0.00	3.08	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	45.48	15.40	27.22	1.07	3.58	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	49.86	18.00	27.70	1.38	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	37.65	16.70	12.11	1.31	0.65	1.31	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	21.02	15.02	3.00	0.00	0.00	0.38	3.00	0.38
CD8+ T Cells, donor3	11383-118B6	35.60	17.93	29.79	0.76	2.02	0.76	3.79	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	21.33	6.19	9.63	2.29	1.38	2.98	0.92	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	20.61	5.75	7.67	0.96	0.00	1.20	1.20	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	20.52	3.28	10.94	0.82	0.27	2.46	2.74	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.12	7.21	10.81	2.70	0.60	2.10	0.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.48	4.80	10.32	0.24	0.96	2.16	1.92	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	18.87	3.41	9.78	1.82	1.14	1.82	1.14	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.38	3.91	9.34	1.96	0.43	3.26	1.74	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	17.11	3.42	12.37	1.32	0.26	1.58	1.32	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	19.93	6.80	9.62	1.88	0.23	1.64	0.94	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	28.07	6.34	21.43	2.11	1.51	2.42	4.53	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	26.15	4.94	14.82	1.16	0.87	1.74	3.20	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	22.91	6.39	13.85	2.66	1.07	2.40	1.33	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	14.88	4.82	15.32	2.63	0.44	1.75	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	14.57	4.10	13.66	2.28	0.91	0.91	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	2.98	14.17	5.97	0.00	0.75	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	17.29	3.24	7.56	1.44	0.72	1.80	2.16	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	17.55	5.75	7.77	1.44	0.29	2.30	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	13.43	3.06	11.55	0.24	0.47	2.59	0.71	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	22.82	6.34	10.77	3.17	0.32	3.49	1.27	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	17.84	5.23	10.46	0.62	0.62	2.15	1.85	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	25.33	4.81	8.34	1.28	0.32	2.56	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	21.80	7.65	11.09	2.29	1.15	3.44	2.29	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.49	4.73	10.25	1.58	1.18	1.97	1.18	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.15	6.81	11.35	0.76	1.51	0.76	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	17.67	4.82	20.88	0.80	0.80	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	12.59	2.80	17.49	3.50	1.40	0.70	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	21.04	4.01	21.04	4.01	1.00	2.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	18.28	7.31	1.83	0.00	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	28.66	11.36	4.45	0.00	0.49	0.49	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	37.67	18.63	6.52	0.63	0.63	0.11	0.21	0.11
Chondrocyte - de diff, donor1	11261-116G1	96.03	41.25	14.91	1.39	1.39	0.69	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	16.35	8.17	2.13	0.36	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	36.07	19.11	6.03	0.23	0.57	0.68	1.71	0.11
Chondrocyte - re diff, donor2	11339-117F7	74.31	39.39	3.58	1.79	0.00	0.90	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	26.29	23.05	4.04	0.00	1.21	0.40	2.43	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	22.49	11.36	3.56	0.57	0.80	0.92	0.57	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	16.89	11.97	2.57	0.21	0.64	0.64	1.28	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	13.54	10.35	2.74	0.00	0.27	0.35	0.71	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	11.92	5.96	3.21	0.37	0.28	0.28	0.18	0.55
Corneal Epithelial Cells, donor1	11526-119I5	1.32	1.32	0.22	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	1.14	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	1.53	0.77	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	0.83	1.16	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	2.21	0.32	0.32	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.54	0.65	0.00	0.00	0.00	0.11	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	60.13	26.65	76.53	2.05	5.81	0.00	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	51.58	32.64	103.15	0.65	11.10	0.65	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	70.17	39.20	93.89	0.48	5.81	0.00	1.45	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	5.34	2.00	1.17	0.17	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	4.69	3.52	0.00	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.96	1.13	1.41	0.28	0.28	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	7.47	1.97	2.36	0.39	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	10.76	5.82	1.75	0.00	0.29	0.00	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	16.00	13.18	3.06	0.94	0.24	0.00	0.71	0.00
Endothelial Cells - Artery, donor3	11413-118E9	10.52	6.49	0.53	0.53	0.00	0.00	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	21.50	10.86	1.99	0.44	0.66	0.00	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	32.86	19.17	3.04	0.61	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	35.52	20.02	5.64	0.85	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	2.97	1.19	0.30	0.00	0.30	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	2.08	1.04	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	1.28	2.27	0.28	0.00	0.00	0.00	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	24.01	5.60	4.00	0.40	0.80	0.80	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	6.29	3.14	1.05	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	52.31	16.40	7.45	1.62	0.75	0.25	0.99	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	20.86	13.90	3.48	0.87	0.22	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	21.49	11.60	6.47	0.61	0.61	0.12	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	4.55	3.41	3.41	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	7.68	2.10	1.40	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	8.64	3.77	1.10	0.00	0.47	0.00	0.47	0.00
Eosinophils, donor1	12244-129H3	60.99	0.00	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	6.60	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	7.13	7.13	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2.44	0.49	0.24	0.00	0.00	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	0.00	0.00	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	30.38	20.53	5.75	0.82	0.41	1.23	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.26	6.57	1.09	0.33	0.22	0.33	0.77	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.82	2.49	0.98	0.00	0.33	0.11	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	33.96	16.25	6.43	0.73	0.36	0.36	1.09	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	45.72	25.38	6.00	1.09	0.27	0.41	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	26.89	15.82	3.59	0.42	1.16	0.32	0.74	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	162.57	54.02	25.03	3.69	1.84	0.79	4.48	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	28.90	19.60	1.99	0.33	1.33	0.00	1.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	9.07	5.90	3.63	0.45	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	4.55	2.27	0.76	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.56	9.46	1.73	0.63	0.47	0.00	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	50.62	33.34	5.76	0.61	1.21	0.30	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	20.81	18.53	3.43	0.38	0.38	0.25	0.51	0.13
Fibroblast - Cardiac, donor6	11460-119B2	23.65	15.61	4.24	0.15	0.45	0.30	0.45	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	8.31	5.36	2.95	0.00	0.27	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.08	6.90	3.88	0.43	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	13.18	2.93	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	10.38	3.69	1.85	0.00	0.46	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	31.38	15.43	5.09	0.34	0.17	0.00	1.02	0.17
Fibroblast - Dermal, donor1	11269-116G9	8.69	8.92	0.23	0.23	0.00	0.23	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	5.19	3.30	0.47	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	9.43	8.10	0.73	0.12	0.24	0.12	0.73	0.00
Fibroblast - Dermal, donor4	11450-119A1	14.70	11.30	1.13	0.11	0.45	0.34	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	11.17	11.51	0.70	0.00	0.17	0.35	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	13.81	10.07	0.65	0.32	0.00	0.16	0.65	0.16
Fibroblast - Gingival, donor1	11237-116D4	20.82	16.87	2.08	0.21	0.42	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	29.61	17.03	3.67	0.26	0.00	1.57	0.79	0.26
Fibroblast - Gingival, donor2	11318-117D4	13.97	10.02	1.84	0.66	0.66	0.13	0.26	0.00
Fibroblast - Gingival, donor3	11394-118C8	15.95	18.37	2.22	0.19	0.19	0.39	0.29	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	55.06	40.52	6.23	0.00	5.19	1.04	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	31.72	18.85	10.22	0.35	0.18	0.53	1.41	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	34.14	19.33	5.30	0.47	1.09	0.62	0.94	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	54.36	20.83	7.98	0.54	0.68	0.95	1.35	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	2.47	1.06	0.35	0.00	0.35	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	45.34	17.55	5.41	0.73	0.88	2.19	0.73	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	51.41	17.86	6.82	0.55	1.09	1.09	1.09	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	51.88	16.12	5.37	1.43	0.22	1.10	0.66	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	39.03	22.16	7.92	0.15	0.88	1.03	1.03	0.15
Fibroblast - Lung, donor1	11270-116H1	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	4.48	1.49	1.49	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	10.76	6.12	0.63	0.21	0.63	0.42	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.83	2.50	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	0.00	5.59	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.12	0.56	0.56	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	8.12	3.65	0.41	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	26.77	12.22	4.07	0.58	0.58	0.78	0.58	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	19.11	14.26	1.06	0.30	0.15	0.30	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	40.70	29.99	4.28	0.61	0.61	0.00	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.10	18.70	3.82	0.00	0.00	1.53	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	19.98	17.55	2.70	0.54	0.00	0.81	1.35	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	30.62	20.99	8.00	0.35	0.58	0.58	1.28	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	33.82	13.04	2.10	0.88	0.22	0.22	0.55	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	10.16	4.88	0.81	0.00	0.00	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.01	0.00	0.67	0.00	0.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.84	7.91	1.19	0.40	0.00	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	86.52	37.11	6.75	1.79	0.00	1.19	2.18	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	45.83	23.45	2.84	1.24	1.42	1.24	1.24	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	42.18	18.33	3.55	0.20	0.39	0.59	1.18	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	83.64	52.35	3.61	3.31	0.60	0.60	3.31	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	56.35	36.70	3.89	1.40	0.54	0.22	0.54	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	62.00	38.47	4.30	1.52	0.00	1.27	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	49.88	22.81	1.64	1.31	0.16	0.82	0.66	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	112.28	66.37	5.61	0.20	0.20	0.60	1.20	0.60
Fibroblast - skin normal, donor2	11561-120D4	52.34	33.45	3.72	2.01	0.60	0.60	0.20	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	53.80	27.20	6.35	1.21	0.30	1.21	1.81	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	22.95	11.02	4.47	0.25	0.33	0.58	0.25	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	40.34	30.09	4.96	0.85	0.34	0.51	0.85	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	89.01	51.56	8.87	1.64	0.99	1.31	1.31	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	48.79	28.33	3.83	1.28	0.43	0.96	0.75	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	24.63	11.98	3.04	0.00	0.51	1.01	1.01	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	42.81	26.97	4.70	0.94	0.78	0.47	1.88	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	110.80	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	4.36	2.61	0.00	0.87	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	18.55	7.97	0.87	0.00	0.17	0.35	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	40.08	13.53	2.60	1.04	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	10.99	4.09	0.51	0.51	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	2.30	0.77	1.53	0.77	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	6.38	0.64	1.28	0.64	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	6.28	5.71	0.29	1.43	0.29	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	10.20	8.55	1.65	1.10	0.00	0.00	1.38	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	9.13	4.11	2.28	1.14	0.23	0.23	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	8.92	3.76	1.19	0.59	0.00	0.00	0.40	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	11.90	7.40	0.53	2.91	0.00	0.00	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	13.37	6.52	2.28	1.30	0.33	0.00	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	6.19	3.10	0.44	0.88	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	9.19	2.69	1.27	1.70	0.14	0.00	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	11.94	5.05	3.32	1.35	0.12	0.00	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.72	2.42	1.61	1.61	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	5.08	4.83	1.49	0.74	0.12	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	6.09	2.35	1.11	1.25	0.14	0.14	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	6.30	1.42	1.02	0.41	0.00	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	7.99	4.34	1.14	0.46	0.00	0.00	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	5.61	1.37	1.87	1.12	0.12	0.00	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	3.93	1.97	1.09	0.44	0.22	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	11.23	6.21	2.07	0.30	0.00	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	12.72	4.93	2.38	0.95	0.00	0.00	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	9.16	4.02	3.80	1.79	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	10.48	3.43	2.42	0.60	0.20	0.00	0.60	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.42	6.79	4.41	0.68	0.17	0.00	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	16.67	5.94	3.28	1.60	0.18	0.00	0.35	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.75	6.97	3.75	0.73	0.10	0.00	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.30	5.81	4.44	1.88	0.00	0.17	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	10.29	6.31	2.66	0.55	0.11	0.00	0.33	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.38	5.66	2.83	1.25	0.25	0.33	0.08	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.40	3.47	4.29	2.65	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	11.55	5.98	2.06	1.86	0.00	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	9.45	5.07	3.34	1.27	0.35	0.00	0.35	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	7.84	6.84	2.67	1.17	0.00	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	9.04	4.63	2.20	0.88	0.00	0.00	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	12.55	6.03	3.69	0.98	0.49	0.00	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.67	5.35	1.30	1.30	0.00	0.16	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.94	5.13	3.53	0.64	0.32	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	6.25	5.59	2.75	0.57	0.00	0.09	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	6.49	4.43	2.37	0.16	0.47	0.16	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	11.56	3.95	2.13	0.30	0.00	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	9.20	5.44	3.03	0.21	0.21	0.00	0.94	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	7.68	7.25	3.73	0.66	0.66	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	8.98	6.45	3.93	0.56	0.28	0.00	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.13	5.00	1.30	0.19	0.19	0.09	0.09	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	8.02	5.08	0.80	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	6.73	4.13	1.68	0.15	0.15	0.00	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	8.29	5.83	2.20	0.13	0.13	0.26	0.39	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	13.28	11.66	4.07	0.81	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	12.17	7.93	3.69	0.18	0.37	0.00	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	13.82	6.14	3.07	0.66	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	30.74	12.89	7.93	0.99	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	17.41	8.71	4.22	0.53	0.53	0.13	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	12.91	10.69	3.83	0.40	0.20	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	32.53	17.79	10.42	1.27	0.76	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	10.55	4.38	1.59	2.19	0.20	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	6.01	2.77	1.54	0.46	0.00	0.15	0.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	8.39	3.48	1.43	1.23	0.20	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	3.76	1.25	1.56	0.63	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	4.80	0.85	0.85	0.57	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	4.61	2.77	2.77	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	2.47	0.00	4.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	8.51	3.48	1.93	0.77	0.00	0.00	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	0.00	1.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	3.48	0.00	0.00	0.00	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	9.76	2.60	1.30	0.65	0.33	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	9.88	1.24	2.88	1.65	0.82	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	3.33	3.33	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.14	3.36	1.12	0.56	0.00	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	7.52	3.60	0.65	0.65	0.00	0.33	1.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	11.74	5.03	2.52	1.68	0.00	0.00	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	11.45	4.77	2.86	0.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	12.23	2.72	0.34	1.02	0.00	0.00	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	2.09	2.09	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	9.16	4.58	1.72	1.15	0.00	0.00	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	8.88	2.96	0.59	0.89	0.00	0.00	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	10.16	3.39	3.39	0.00	0.00	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	16.98	4.14	2.07	0.83	0.41	0.00	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	13.12	4.37	1.84	0.92	0.23	0.23	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	5.27	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.38	2.31	1.54	1.15	0.00	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	10.76	4.56	3.26	1.30	0.33	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	9.36	4.01	0.67	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	13.48	5.01	3.85	0.39	0.77	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	12.67	4.45	2.74	1.37	0.00	0.34	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	7.45	2.48	0.00	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.44	2.83	1.89	3.77	0.47	0.00	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.29	5.43	7.85	1.81	0.00	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	15.26	5.09	2.54	1.53	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	15.95	5.18	2.39	0.80	0.00	0.00	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.31	7.89	6.41	0.99	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	23.61	4.72	2.36	3.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.67	5.25	4.67	2.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	15.36	6.58	4.83	2.19	0.00	0.00	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	10.17	4.24	1.70	0.85	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.95	2.39	3.58	0.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	19.90	5.82	4.85	0.97	0.49	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	6.85	2.28	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	18.30	15.80	3.33	0.42	0.42	0.42	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1.12	3.37	2.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.03	5.39	0.32	0.00	0.63	0.00	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.01	5.43	0.00	0.00	0.42	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	16.94	9.17	1.62	0.93	0.35	0.35	0.93	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	19.92	9.28	2.36	1.52	0.17	0.00	0.51	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	20.93	6.60	1.82	1.59	0.00	0.00	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	19.24	8.31	1.31	0.87	0.22	0.66	1.75	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	20.20	10.75	1.50	1.29	0.21	0.43	1.29	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	17.22	7.53	2.15	1.51	0.00	0.65	0.43	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.81	10.09	1.49	0.87	0.25	0.25	0.62	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	21.10	10.81	2.23	2.06	0.17	0.00	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	18.90	9.93	2.24	1.28	0.00	0.32	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	1.68	2.24	0.56	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	0.87	1.73	0.43	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	5.29	2.64	0.00	0.00	0.00	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.64	2.12	0.71	0.71	0.35	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.18	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	30.60	13.81	6.47	1.57	1.05	1.05	1.75	0.17
Hepatocyte, donor1	11523-119I2	81.11	18.16	26.63	3.63	1.21	0.00	4.84	0.00
Hepatocyte, donor2	11603-120I1	77.57	17.24	26.93	1.08	3.23	0.00	5.39	0.00
Hepatocyte, donor3	11684-122I1	53.38	25.77	15.34	3.07	1.84	0.00	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	248.02	39.16	210.17	7.83	8.48	24.15	5.87	22.19
Intestinal epithelial cells (polarized), donor1	11246-116E4	16.43	4.37	3.67	1.92	0.00	0.00	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	19.76	15.78	3.02	0.55	0.27	0.55	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	2.56	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	0.00	1.62	0.00	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	1.67	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	1.32	2.65	1.32	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	4.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	4.41	0.00	0.63	0.00	0.00	1.26	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	0.00	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	2.58	1.29	0.00	0.00	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	0.00	0.00	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1.63	1.63	0.00	0.00	0.00	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.26	0.00	1.26	0.00	0.00	0.84	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.82	2.41	0.00	0.00	0.00	0.80	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.92	0.92	0.92	0.00	0.00	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.89	0.94	0.00	0.00	0.00	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1.81	0.00	3.63	0.00	0.00	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	2.15	0.00	4.30	1.08	0.00	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	1.27	1.27	0.00	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.91	0.64	1.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	1.82	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	0.71	1.43	0.00	0.00	0.71	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	2.47	2.47	1.23	0.00	0.00	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	3.51	1.76	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	3.48	2.09	0.70	0.00	0.00	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	6.64	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.87	0.87	1.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	6.97	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	3.20	1.07	0.00	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1.39	4.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	9.08	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	0.00	1.06	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	9.06	2.69	0.41	0.24	0.00	0.00	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	3.51	1.17	1.17	1.17	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	23.95	9.09	1.33	0.95	0.19	0.00	1.99	0.09
Keratinocyte - oral, donor1	11251-116E9	12.26	4.43	1.59	0.34	0.00	0.11	0.11	0.00
Keratocytes, donor1	11527-119I6	10.66	5.50	3.44	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	0.00	1.17	2.34	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	19.17	11.07	3.95	0.20	0.00	0.00	1.38	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	0.00	0.00	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	8.63	7.55	0.00	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	22.03	15.34	6.46	1.15	0.46	0.12	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	37.03	28.36	5.85	1.11	0.61	0.10	0.50	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	4.15	3.56	0.47	0.12	0.24	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.35	2.23	0.28	0.00	0.28	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.59	4.09	1.73	0.16	0.16	0.00	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.76	0.54	1.61	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	0.95	1.26	0.32	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	2.70	1.29	0.86	0.32	0.00	0.00	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.34	3.28	1.64	0.00	0.00	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.01	0.00	0.25	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	3.94	2.25	0.14	0.00	0.00	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	6.72	3.96	1.19	0.40	0.00	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.43	2.33	1.55	0.19	0.00	0.00	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1.85	0.37	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.92	2.09	0.35	0.00	0.00	0.00	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	2.39	2.39	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	3.02	1.65	0.69	0.14	0.27	0.00	0.69	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.85	1.54	0.31	0.31	0.00	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1.87	0.62	0.62	0.00	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	2.38	1.83	0.91	0.00	0.18	0.00	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.29	2.63	0.66	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	0.88	0.88	0.00	0.00	0.00	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.24	1.24	0.75	0.00	0.25	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	4.85	2.42	0.00	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.12	2.15	1.08	0.27	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	4.39	1.36	0.45	0.00	0.15	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.18	1.56	1.04	0.00	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.75	3.56	0.21	0.00	0.21	0.00	1.05	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.01	1.20	0.15	0.00	0.30	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	1.38	0.69	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.39	2.07	1.13	0.00	0.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1.48	0.85	0.53	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	5.81	2.42	0.97	0.48	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.31	0.66	0.66	0.00	0.33	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	1.61	1.24	0.37	0.00	0.25	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	9.26	5.92	2.59	0.37	0.00	0.00	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	4.45	0.99	0.49	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1.10	1.51	0.27	0.14	0.14	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	7.72	3.22	1.93	0.00	0.32	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	5.78	3.65	2.13	0.00	0.00	0.00	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.98	4.34	0.70	0.14	0.14	0.00	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	3.56	1.07	0.00	0.36	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	0.93	0.31	0.62	0.00	0.00	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.66	2.51	0.00	0.00	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	2.94	0.33	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.18	0.47	0.00	0.00	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	6.31	2.97	0.62	0.25	0.00	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	1.28	0.77	0.26	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.39	0.90	0.90	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	5.37	1.53	0.77	0.77	0.00	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.94	1.48	0.00	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	4.23	0.42	0.42	0.00	0.00	0.42	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.81	0.70	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	2.80	0.93	0.00	1.87	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.67	1.03	0.00	0.00	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	2.38	0.00	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	4.52	1.13	0.90	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.67	3.20	1.16	2.04	0.00	0.29	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.31	7.20	2.25	0.90	0.00	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	7.32	0.68	0.54	0.41	0.00	0.14	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6.16	0.51	1.54	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	14.47	4.94	1.76	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.99	3.33	2.67	1.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	7.64	1.53	1.02	0.51	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.87	6.40	2.13	0.80	0.27	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	15.49	3.78	0.38	1.32	0.00	0.19	0.57	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	5.52	1.23	0.00	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	4.89	0.00	0.00	2.45	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	18.53	3.54	0.42	1.04	0.00	0.00	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.77	2.52	2.24	1.40	0.00	0.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	1.03	0.00	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.06	2.32	0.58	2.61	0.00	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	13.45	4.78	0.60	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	20.47	4.98	0.00	4.43	0.00	1.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	4.24	1.77	0.71	0.00	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	5.53	1.84	0.74	0.74	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	5.76	1.15	1.15	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	2.69	1.15	0.77	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	3.40	1.13	1.13	0.00	0.00	0.00	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	4.92	4.92	1.64	0.82	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	4.07	1.36	0.45	1.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	8.62	0.72	0.72	0.72	0.00	0.72	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.93	2.24	0.75	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	5.20	1.11	0.00	0.74	0.00	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	11.20	0.43	1.72	0.43	0.00	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.99	1.71	0.86	0.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.33	1.00	0.33	0.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	4.22	0.00	1.21	1.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.84	0.71	0.00	0.00	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	7.91	0.69	0.34	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	3.76	0.54	0.54	0.00	0.00	0.00	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	4.71	2.69	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	5.56	2.96	0.37	0.37	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	2.33	1.16	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	3.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	5.60	2.40	0.80	0.80	0.40	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	4.60	2.30	1.53	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	2.96	0.00	0.99	0.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	4.70	1.88	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	2.70	1.35	0.00	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	0.00	0.00	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.89	0.89	0.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	3.13	1.56	0.39	0.00	0.00	0.78	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	2.64	0.66	0.00	0.66	0.00	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	3.63	2.08	0.00	0.52	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	3.06	0.44	0.00	0.00	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.39	2.24	2.24	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	3.53	0.88	0.44	0.44	0.00	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	4.63	2.31	0.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	5.57	2.03	0.00	1.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	6.25	1.92	0.96	0.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	4.37	2.39	0.00	0.80	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.08	1.82	0.61	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.69	2.08	0.69	0.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	7.60	1.52	0.38	0.76	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	4.13	1.55	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	2.42	1.21	1.81	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	4.44	3.49	0.95	0.63	0.00	0.00	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	2.13	0.00	0.00	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2.30	0.57	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	3.09	1.03	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.95	0.71	0.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.67	0.57	0.00	1.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	1.66	0.83	0.00	0.42	0.00	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	1.25	0.84	0.42	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	4.18	0.46	0.00	0.46	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.69	0.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	3.21	1.60	0.00	0.00	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	3.23	1.21	0.40	0.40	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	1.84	1.84	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	0.89	0.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	2.28	1.14	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	6.57	0.55	0.55	1.09	0.00	0.00	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	3.12	0.45	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	3.12	0.26	0.26	0.26	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	3.32	0.00	0.00	0.66	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	11.17	6.61	1.37	0.00	0.00	0.00	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	7.16	7.89	0.37	0.00	0.73	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	6.55	6.95	0.52	0.13	0.00	0.39	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	20.18	5.84	0.53	0.53	0.00	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	60.53	15.05	3.49	2.22	0.63	0.00	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	43.09	9.31	1.81	3.34	0.56	0.14	0.56	0.00
Mammary Epithelial Cell, donor1	11273-116H4	18.83	6.48	1.00	0.40	0.30	0.10	0.60	0.10
Mammary Epithelial Cell, donor2	11350-117G9	22.01	6.66	0.87	1.16	0.58	0.00	1.16	0.00
Mammary Epithelial Cell, donor3	11422-118F9	2.99	2.24	0.00	0.00	0.00	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	534.21	94.23	218.30	33.90	6.78	12.88	1.36	7.46
Mast cell, donor1	11563-120D6	63.26	26.71	13.63	1.08	1.41	5.30	0.54	1.08
Mast cell, donor2	11565-120D8	28.53	16.94	5.35	0.59	0.59	0.30	0.30	0.00
Mast cell, donor3	11566-120D9	24.54	13.06	4.05	0.68	0.90	0.23	0.00	0.23
Mast cell, donor4	11567-120E1	23.05	12.06	3.55	0.00	0.35	0.18	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	121.43	26.28	45.91	3.44	2.99	9.09	1.22	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	75.88	9.92	40.86	1.17	0.58	7.00	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	26.50	7.80	7.00	0.46	0.34	2.75	0.57	0.80
Mast cell, expanded, donor8	11941-126A6	27.95	7.87	3.68	0.00	0.84	1.67	0.17	0.17
Melanocyte - dark, donor1	11502-119F8	17.61	8.36	3.68	0.50	0.70	0.00	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	30.46	13.15	6.92	0.00	0.69	1.04	1.73	0.00
Melanocyte - dark, donor3	11663-122F7	11.01	8.84	1.81	0.07	0.29	0.07	0.22	0.00
Melanocyte - light, donor1	11274-116H5	1.65	0.94	0.47	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	2.60	0.87	1.73	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	9.27	6.98	1.15	0.10	0.21	0.00	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	13.18	5.11	1.88	0.54	0.00	0.27	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	7.77	3.75	2.68	0.00	0.27	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	11.04	6.20	2.23	0.25	0.12	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	13.64	4.40	2.20	1.32	0.88	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	25.92	6.85	2.45	0.08	0.24	0.08	0.49	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	19.39	11.12	1.43	0.29	0.00	0.86	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	41.86	11.67	5.84	0.60	0.60	0.20	0.20	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.18	12.20	0.72	0.72	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.45	12.71	3.39	0.64	0.64	0.42	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.07	8.04	3.02	0.50	0.50	1.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	3.96	1.32	0.22	0.22	0.00	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2.19	2.92	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	3.68	1.43	0.00	0.00	0.00	0.20	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	24.24	18.56	0.97	0.69	0.55	0.14	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	6.69	2.97	0.37	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	42.89	12.50	3.29	0.26	0.26	0.13	1.05	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	16.32	3.86	0.59	0.00	0.00	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	2.34	7.01	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	4.48	4.48	0.64	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	21.27	11.34	1.06	0.00	0.00	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	32.84	21.58	3.13	0.31	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.05	13.06	2.18	2.18	0.00	0.00	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	21.21	15.65	3.98	0.53	0.53	0.00	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	15.01	11.51	2.00	0.00	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	21.68	13.95	3.90	0.87	0.36	0.14	1.37	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	4.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.08	7.14	2.71	0.00	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	3.53	3.24	1.77	0.00	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.30	10.23	2.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	2.90	2.70	0.41	0.21	0.00	0.21	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	8.51	9.01	0.50	0.00	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	3.72	1.40	1.40	0.00	0.00	0.93	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.72	5.08	2.24	0.00	0.00	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	3.17	2.77	0.40	0.00	0.00	1.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	5.31	1.77	1.77	0.88	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	3.80	2.66	0.38	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	2.63	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.19	7.64	1.91	0.21	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	6.56	4.77	1.49	0.60	0.00	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	1.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.79	8.03	1.51	0.00	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.33	1.43	0.71	0.24	0.00	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.66	1.11	0.00	0.00	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.97	5.99	1.38	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.89	2.52	0.84	0.00	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.08	3.87	1.63	0.00	0.20	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.94	6.22	1.50	0.00	0.43	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1.11	0.89	0.00	0.22	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.45	3.29	1.10	0.44	0.22	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.51	0.51	1.01	0.00	0.51	1.01	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.16	3.81	0.54	0.00	0.00	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.06	0.88	0.59	0.00	0.00	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.32	3.36	0.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	2.80	1.60	0.40	0.00	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.00	5.01	0.50	0.00	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.69	3.07	0.00	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	2.21	0.00	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.92	0.00	1.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.96	2.73	1.49	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	2.09	0.00	0.00	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	2.21	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.50	2.05	1.03	0.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.31	1.31	0.00	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.00	0.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	4.49	1.96	0.56	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.83	1.25	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.58	0.58	0.00	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2.41	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1.25	2.92	0.00	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.92	2.77	1.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.14	1.71	1.14	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.69	1.24	0.14	0.00	0.00	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	3.89	2.07	0.26	0.00	0.00	0.78	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1.29	0.86	0.00	0.00	0.00	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	1.27	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	2.14	1.60	0.53	0.00	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	2.69	4.49	0.60	0.00	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1.27	0.99	0.14	0.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3.50	0.32	0.32	0.00	0.00	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1.11	1.55	0.22	0.00	0.00	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.14	0.38	0.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	2.84	1.99	0.57	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	3.20	2.21	0.25	0.00	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.30	0.65	0.65	0.00	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	2.65	3.23	0.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.04	2.59	0.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	5.77	4.53	2.06	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2.98	2.98	0.60	0.00	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	7.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	3.56	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	5.59	3.94	1.31	0.00	0.33	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	5.26	2.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.13	3.95	0.79	0.00	0.00	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	2.79	0.00	0.00	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	8.26	5.26	1.13	0.00	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	8.26	4.26	0.80	0.00	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	6.67	3.05	1.70	0.00	0.23	0.00	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	9.58	3.68	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	5.86	2.56	0.73	0.00	0.37	0.37	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	4.67	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.69	3.74	4.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	0.00	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	3.03	3.03	2.02	0.00	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.85	4.22	2.53	0.00	0.00	0.00	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	4.09	5.45	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	1.27	1.91	0.00	1.91	0.00	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	15.39	8.91	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	6.04	1.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	3.26	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	9.50	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	17.23	9.91	2.37	0.65	0.00	0.65	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	17.25	9.41	2.61	0.00	2.61	0.00	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	5.34	3.34	0.67	0.67	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.10	10.43	0.00	1.25	0.00	1.25	0.00	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	19.96	23.77	4.18	0.57	0.38	0.95	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	9.58	6.38	0.00	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	5.44	2.04	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	49.62	18.38	7.35	0.00	3.68	0.00	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.63	7.95	8.37	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.74	14.41	1.63	0.70	0.00	1.39	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.57	6.22	2.16	0.00	1.08	1.08	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	20.39	10.51	3.57	0.42	1.05	0.63	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	244.96	111.35	66.81	0.00	0.00	0.00	22.27	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	10.42	10.42	2.98	0.00	1.49	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.51	11.91	4.60	1.35	0.54	0.27	1.08	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.48	11.56	1.59	0.23	0.45	0.00	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.88	6.86	1.96	0.16	0.82	0.33	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	17.86	10.57	2.92	0.55	0.91	0.36	0.36	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.02	9.02	1.06	0.00	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.00	4.20	3.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.30	12.14	7.22	0.33	0.33	1.31	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.46	7.48	0.65	0.00	0.49	0.33	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.93	11.11	5.12	0.18	1.23	0.71	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	9.14	1.41	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	7.36	9.19	2.76	0.00	0.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.89	8.35	6.43	0.32	1.61	0.64	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.87	18.28	4.14	0.00	1.38	0.69	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	40.46	12.64	0.00	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	10.92	9.36	4.01	0.22	0.67	0.45	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.04	9.31	1.27	0.00	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.97	6.17	4.03	0.00	0.47	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.03	13.74	5.15	0.00	2.15	1.29	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	180.56	189.58	45.14	9.03	0.00	9.03	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.33	11.00	2.67	0.33	1.00	0.00	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	7.21	5.86	0.00	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.13	7.94	4.76	0.00	0.40	0.00	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	8.36	1.86	0.93	2.79	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.89	18.92	6.81	0.38	0.00	0.38	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.29	10.10	6.52	0.33	0.33	0.00	0.33	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	5.23	2.61	0.87	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.00	9.95	9.50	0.45	1.36	0.90	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	10.58	4.41	0.88	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	11.30	3.32	0.66	0.66	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.88	15.38	3.47	0.00	1.98	0.00	1.49	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.40	9.57	4.59	1.15	1.53	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	18.75	26.01	4.54	0.91	0.30	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	17.24	10.83	9.73	0.00	1.11	0.00	0.22	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	5.42	5.42	0.00	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	81.75	35.77	45.99	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	11.58	12.80	4.27	1.83	0.61	0.00	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.39	12.59	5.04	0.00	0.31	0.00	0.94	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.99	10.29	2.42	0.00	0.61	0.30	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	5.54	2.37	0.00	1.58	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	36.28	23.81	5.67	0.00	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	75.87	50.58	25.29	0.00	0.00	5.06	10.12	0.00
Myoblast, donor1	11241-116D8	26.71	11.06	2.11	0.75	0.25	0.25	0.75	0.37
Myoblast, donor2	11322-117D8	18.41	11.12	1.73	0.00	0.38	0.00	0.96	0.00
Myoblast, donor3	11398-118D3	20.35	9.92	1.35	0.00	0.50	0.67	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	142.43	28.02	97.34	9.63	7.00	28.75	2.92	13.28
Natural Killer Cells, donor1	11230-116C6	32.29	10.46	9.23	0.31	0.62	0.92	0.92	0.92
Natural Killer Cells, donor2	11311-117C6	16.89	9.35	1.51	0.30	0.60	0.90	1.51	0.30
Natural Killer Cells, donor3	11387-118C1	20.43	10.86	6.63	0.18	0.37	1.10	1.47	0.18
Neural stem cells, donor1	11275-116H6	15.24	3.99	7.98	0.00	1.09	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	23.11	26.96	21.18	1.93	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	11.38	6.83	5.69	1.14	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	11.45	8.15	12.55	0.22	0.44	0.22	0.22	0.00
Neurons, donor3	11655-122E8	10.69	3.29	8.22	0.82	0.82	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	12.99	3.71	0.93	0.93	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	11.60	5.80	0.00	0.00	0.00	0.00	5.80	0.00
Neutrophils, donor3	11390-118C4	12.22	2.44	1.83	0.00	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	12.47	10.45	2.02	0.12	0.36	0.00	0.71	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	7.81	5.21	1.30	0.00	0.00	0.00	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	8.82	5.62	2.01	0.20	0.60	0.00	1.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	13.77	8.12	2.89	0.28	0.41	0.14	0.69	0.28
Olfactory epithelial cells, donor2	11934-125I8	30.98	12.30	2.75	0.58	0.58	0.29	2.75	0.00
Olfactory epithelial cells, donor3	11935-125I9	19.86	7.83	2.27	0.45	0.57	0.23	1.14	0.23
Olfactory epithelial cells, donor4	11936-126A1	28.34	13.54	6.92	0.29	0.97	0.49	1.27	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	19.26	12.04	1.81	0.60	0.60	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	14.68	5.96	2.34	0.00	0.64	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.86	10.55	9.31	0.00	0.00	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	1.76	0.98	0.59	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	71.64	20.37	6.32	0.70	1.40	1.40	1.40	0.00
Osteoblast, donor3	11426-118G4	7.29	4.80	0.89	0.00	0.53	0.18	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	39.84	15.75	4.63	0.67	1.10	0.42	1.01	0.17
Pericytes, donor1	11491-119E6	2.45	0.78	0.56	0.00	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	1.58	0.68	0.91	0.23	0.23	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	3.46	2.64	0.41	0.00	0.20	0.20	0.00	0.00
Perineurial Cells, donor1	11499-119F5	34.13	23.62	6.22	0.68	0.57	0.45	0.45	0.00
Perineurial Cells, donor2	11579-120F4	62.11	28.52	7.54	0.83	0.55	0.37	0.46	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	29.32	5.74	24.22	0.64	1.27	0.32	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	11.51	6.61	8.33	0.00	1.71	0.24	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.33	7.38	6.86	0.13	0.39	0.26	0.65	0.13
Placental Epithelial Cells, donor1	11278-116H9	4.78	0.96	0.24	0.24	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	15.52	3.33	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.52	2.16	0.98	0.00	0.20	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.39	6.65	3.16	0.32	0.63	0.63	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	22.70	8.25	2.44	0.19	0.56	0.56	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	46.86	28.85	5.09	0.65	0.65	0.78	0.13	0.39
Preadipocyte - breast, donor2	11328-117E5	14.41	10.58	2.03	0.23	0.45	0.68	0.00	0.45
Preadipocyte - omental, donor1	11468-119C1	37.08	12.68	5.43	0.21	0.64	0.64	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	34.04	17.90	3.06	0.44	0.00	0.44	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	34.38	24.64	5.87	0.57	0.57	0.29	0.57	0.00
Preadipocyte - perirenal, donor1	11469-119C2	7.87	4.92	1.97	1.97	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	8.91	4.61	0.31	0.00	0.31	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	28.51	17.18	4.43	0.35	0.35	1.06	1.59	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	27.42	18.22	4.77	0.34	0.51	0.51	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	39.12	18.26	5.22	0.28	0.84	0.37	0.19	0.09
Preadipocyte - visceral, donor2	11357-117H7	46.02	20.71	4.14	1.84	1.38	0.46	1.84	0.00
Preadipocyte - visceral, donor3	11429-118G7	21.94	14.94	3.24	0.42	0.31	0.21	0.73	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	19.46	4.22	3.62	1.66	0.00	0.15	0.45	0.00
Prostate Epithelial Cells, donor2	11331-117E8	6.09	2.98	0.00	0.00	0.14	0.00	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	12.86	5.94	0.37	0.37	0.00	0.06	0.86	0.00
Prostate Stromal Cells, donor1	11254-116F3	59.34	15.49	15.95	1.14	0.80	0.80	0.91	0.00
Prostate Stromal Cells, donor2	11332-117E9	64.91	17.39	9.68	1.61	1.26	0.18	6.10	0.36
Prostate Stromal Cells, donor3	11405-118E1	32.01	17.62	7.72	0.31	0.83	0.21	1.25	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	2.19	0.36	0.73	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	10.19	4.30	1.04	0.28	0.14	0.00	0.21	0.00
Renal Epithelial Cells, donor1	11517-119H5	0.00	0.51	0.00	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	2.13	2.13	0.00	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	13.97	6.46	1.06	0.32	0.11	0.00	0.42	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1.36	2.72	0.68	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	2.56	1.75	0.27	0.13	0.00	0.00	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	24.42	9.77	3.77	0.89	0.00	0.44	2.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	1.33	0.00	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	3.08	0.22	0.88	0.22	0.22	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.13	0.63	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	0.55	1.11	0.28	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	3.49	1.34	0.81	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.95	0.84	0.42	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	0.77	0.77	0.58	0.00	0.00	0.00	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	13.48	12.45	1.30	0.26	0.52	0.00	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3.41	0.85	0.28	0.28	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	0.00	0.00	0.00	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	11.54	3.01	2.26	0.50	0.00	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	63.48	24.59	5.61	1.34	0.27	0.00	1.20	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	83.09	16.97	58.07	7.15	4.47	5.36	1.79	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	233.36	30.27	112.83	18.71	2.20	6.05	37.43	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	256.96	60.33	167.06	24.36	2.32	5.22	5.22	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	38.23	25.09	11.44	1.43	0.78	2.08	0.78	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	19.86	10.82	6.55	0.70	0.79	1.79	1.19	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	36.36	20.52	10.93	1.23	0.22	1.00	0.33	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	45.52	33.00	13.02	2.73	0.62	2.23	1.49	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	20.86	13.05	6.99	0.82	0.70	1.63	1.17	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	26.58	17.57	10.17	1.16	1.16	1.39	2.54	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	20.67	16.43	9.45	1.23	0.55	0.82	0.82	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	20.12	11.19	6.96	0.61	0.76	1.06	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	24.37	14.16	10.03	0.90	0.90	1.25	0.36	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	23.24	18.08	8.18	1.15	0.57	1.00	2.30	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.24	11.48	6.33	0.43	0.21	1.61	0.97	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	21.02	16.82	6.64	1.33	1.11	1.33	1.11	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	19.88	14.72	10.51	1.91	0.38	1.53	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	19.19	14.53	5.40	0.37	0.19	1.30	0.56	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	44.16	15.03	13.34	1.50	0.75	1.50	2.63	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	19.91	20.83	7.70	1.19	0.66	0.93	0.66	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	22.10	17.72	7.20	1.75	0.49	1.65	1.27	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	23.49	15.66	10.50	1.34	0.76	1.91	1.34	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	22.75	18.69	7.80	0.64	0.43	1.60	0.75	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	16.54	10.65	7.85	0.56	0.56	1.12	1.12	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	26.32	14.01	8.72	0.17	0.00	1.03	0.68	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	18.23	19.33	8.75	1.09	0.36	1.09	0.18	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	17.41	13.73	4.78	0.61	0.49	1.84	1.96	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	24.31	20.55	9.54	1.07	0.81	1.48	1.88	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	27.83	12.97	10.61	1.18	0.24	2.36	0.71	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	20.44	13.10	7.74	0.40	0.20	1.39	1.19	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	23.15	14.03	7.95	0.47	0.47	2.34	1.64	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	21.98	20.94	7.88	1.45	0.21	2.28	1.24	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	25.44	12.17	6.42	0.44	0.66	1.33	1.33	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	19.43	11.28	6.89	0.42	0.42	1.04	1.04	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	25.44	18.57	9.82	1.21	0.40	1.88	1.08	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	14.13	15.84	5.28	0.68	0.51	1.19	0.68	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	20.44	16.19	9.25	0.77	0.00	1.35	2.51	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	28.89	17.71	8.42	1.03	0.69	1.89	0.86	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.38	17.15	4.66	0.69	0.82	0.96	0.41	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	27.25	16.91	9.52	0.82	0.82	1.97	2.13	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	22.50	18.75	10.74	1.36	0.17	2.05	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	25.15	20.12	9.17	1.78	0.44	1.33	1.33	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	20.79	17.86	10.93	0.53	0.53	1.87	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	29.59	29.73	15.35	1.80	0.83	1.66	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	23.81	20.00	11.19	0.48	1.19	0.95	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	32.65	23.58	19.95	2.22	0.81	2.42	1.01	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	36.73	24.96	19.40	2.73	1.51	1.32	1.04	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	48.56	29.35	23.41	2.79	1.05	2.10	5.24	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	36.57	26.59	22.67	3.02	2.12	3.63	1.21	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	54.83	26.19	34.39	4.65	1.47	2.94	1.71	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	212.80	56.33	97.96	10.77	4.08	9.61	2.47	5.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	83.96	39.55	35.90	7.30	1.22	2.43	3.04	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	61.79	25.32	38.58	3.92	0.30	3.62	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	95.45	35.51	51.80	5.20	2.49	2.94	3.39	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	133.59	47.63	82.97	8.69	3.89	3.89	5.39	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	125.39	44.87	71.08	7.79	3.07	3.54	2.24	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	91.57	33.94	52.08	5.55	1.71	3.84	1.92	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	143.63	59.50	80.53	13.82	3.00	1.80	3.61	4.21
Schwann Cells, donor1	11498-119F4	3.57	2.44	0.75	0.38	0.00	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	13.61	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	10.08	3.94	1.75	0.00	0.66	0.00	1.53	0.22
Sebocyte, donor1	11220-116B5	4.93	2.74	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	1.84	1.38	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	1.24	2.27	0.21	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	62.95	31.48	21.54	1.66	3.31	1.66	0.00	1.66
Sertoli Cells, donor2	11333-117F1	48.01	16.95	0.00	0.00	0.00	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	13.55	4.31	2.46	0.26	0.53	0.18	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	10.84	4.34	11.57	0.00	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	4.18	3.34	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	18.38	10.05	2.36	0.63	0.63	0.31	0.63	0.16
Skeletal Muscle Cells, donor5	11455-119A6	13.97	8.47	2.23	0.30	0.45	0.15	0.30	0.30
Skeletal Muscle Cells, donor6	11459-119B1	18.78	14.31	1.39	0.62	0.15	0.46	0.77	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	35.03	17.64	3.78	0.25	0.38	0.38	0.76	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.83	13.84	1.85	0.29	0.57	0.00	1.85	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	14.48	12.60	2.88	0.50	0.89	0.79	0.20	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	27.47	8.17	5.90	0.34	0.42	0.42	0.25	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	4.34	2.90	0.00	0.72	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	2.75	2.48	0.83	0.00	0.00	0.00	0.14	0.00
Skin - palm, donor1	10286-104F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.17	1.87	0.14	0.14	0.14	0.00	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	10.63	4.91	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	3.89	2.60	0.26	0.26	0.00	0.13	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	24.47	7.23	1.39	0.56	0.00	0.28	0.42	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	10.27	7.31	0.42	0.42	0.42	0.00	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	19.03	12.69	1.06	1.27	0.21	0.21	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	28.78	15.96	2.17	0.30	0.22	0.22	0.45	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.32	4.94	0.93	0.31	0.31	0.00	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	91.38	57.58	13.34	3.11	1.33	1.56	2.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	15.28	11.17	2.94	0.00	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.35	1.77	2.65	0.44	0.22	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.48	1.97	1.18	0.00	0.79	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	15.45	7.73	1.55	0.77	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	15.01	3.00	1.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.38	4.52	1.20	0.13	0.27	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	33.03	19.28	8.64	0.66	1.11	1.55	2.44	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	13.32	12.16	3.33	0.90	0.26	0.13	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	23.12	10.74	2.93	1.30	0.65	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	26.87	17.42	5.32	0.89	0.89	0.59	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.36	15.66	3.27	1.00	0.85	0.00	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.63	0.98	0.49	0.00	0.00	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	8.52	3.35	2.74	0.00	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.36	5.30	0.76	0.00	0.00	0.25	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.01	5.72	0.95	0.48	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	23.60	9.00	2.51	0.29	0.15	0.15	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	17.65	10.76	3.66	0.43	0.00	0.22	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	19.73	11.86	3.15	0.52	0.63	0.73	0.84	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.35	3.56	0.77	0.15	0.15	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	10.78	8.62	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.05	5.98	3.59	0.90	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.07	1.37	0.34	0.68	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	32.98	12.96	3.77	0.47	0.39	0.16	0.79	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	25.66	10.47	4.53	0.40	0.60	0.50	0.20	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	88.97	27.31	22.53	3.41	1.82	0.68	4.32	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.06	4.23	4.83	0.60	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	26.23	16.96	1.85	0.26	0.26	0.79	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	56.99	30.23	6.66	1.33	0.93	0.67	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	52.09	26.55	9.77	1.50	1.63	0.50	2.50	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	22.83	15.73	3.80	0.00	1.27	0.25	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	29.70	14.02	3.47	0.15	0.75	0.45	0.30	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	6.00	1.50	0.00	0.75	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1.29	1.29	0.00	0.00	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.95	7.44	1.40	0.00	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	26.25	11.11	3.03	0.50	0.50	0.00	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	12.54	9.09	2.51	0.63	0.94	0.00	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.88	0.88	0.00	0.00	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	24.83	17.58	2.67	0.25	0.42	0.58	0.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.54	7.47	2.34	0.00	0.47	0.47	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.06	1.58	0.72	0.14	0.29	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.65	6.37	1.78	0.76	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	3.01	2.26	0.94	0.19	0.19	0.19	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	40.25	21.52	2.10	0.56	0.70	0.14	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	37.62	21.28	4.19	0.75	0.34	0.34	0.59	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	1.90	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.34	1.71	1.47	0.24	0.00	0.24	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	55.46	25.41	13.26	1.55	1.77	0.44	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	36.86	25.75	3.51	0.29	0.29	0.59	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.69	12.63	2.14	0.58	0.00	0.00	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.78	3.70	2.12	0.26	0.26	0.00	1.06	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	30.87	11.16	7.44	1.12	1.12	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	19.04	6.47	3.95	0.36	0.00	0.36	2.16	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.90	5.39	3.41	0.00	0.28	0.57	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	37.81	8.27	5.12	2.76	0.00	3.15	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	33.78	12.95	6.35	1.02	0.00	1.02	1.78	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	34.74	20.37	7.19	0.80	0.00	0.40	2.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	13.79	5.85	5.02	0.42	0.42	0.42	1.67	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	19.71	5.50	1.83	0.00	0.00	0.92	0.92	0.00
Synoviocyte, donor1	11291-117A4	29.46	10.10	4.71	0.00	1.18	0.00	1.18	0.17
Synoviocyte, donor2	11368-117I9	50.45	31.51	8.21	1.17	0.17	0.84	1.34	0.17
Synoviocyte, donor3	11440-118H9	21.00	18.32	3.57	0.67	0.00	0.22	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	5.72	2.14	1.07	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	1.85	1.16	0.46	0.23	0.23	0.00	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	17.85	2.94	0.93	0.43	0.22	0.07	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	3.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	1.72	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	62.50	26.82	5.78	2.58	0.12	0.62	0.37	0.00
Urethra, donor2	10319-105A4	8.99	12.59	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	0.80	0.53	0.27	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.60	1.60	0.00	0.40	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	0.46	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	20.28	13.37	1.11	1.34	0.00	0.00	1.34	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	24.91	8.90	20.47	0.00	0.00	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	30.02	4.29	15.73	0.00	0.00	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	13.01	3.42	6.16	0.00	0.00	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	19.28	7.23	11.02	1.03	0.69	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	22.08	2.32	13.94	0.58	1.16	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	15.62	9.37	9.37	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	26.62	7.34	19.27	1.84	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	11.87	2.74	9.13	0.00	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	5.55	4.07	0.99	0.37	0.00	0.25	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	17.60	7.92	3.52	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	29.05	20.11	0.28	0.56	0.00	0.84	0.56	0.00
achilles tendon, donor2	10292-104G4	8.27	0.00	2.07	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	11.22	4.84	6.37	0.25	0.51	0.25	0.76	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	64.08	21.13	56.19	3.25	3.25	4.64	0.46	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	480.29	72.77	122.86	15.08	3.92	11.04	1.78	8.67
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	298.78	65.31	126.53	9.52	10.88	17.69	5.17	13.06
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	141.39	25.86	48.35	6.18	1.12	10.12	8.15	3.94
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	212.75	54.77	62.81	5.92	5.92	19.67	1.90	9.52
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	55.80	8.98	25.32	1.91	0.27	0.00	1.09	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	178.90	36.13	124.26	11.90	3.97	1.32	5.29	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	238.89	44.10	193.15	11.84	8.98	12.25	9.39	5.72
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	84.26	24.85	100.96	2.33	5.05	4.27	1.55	5.82
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	267.72	38.27	130.82	18.22	5.52	26.50	12.51	16.56
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	202.83	27.30	136.52	11.70	7.80	19.50	7.80	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	31.84	15.80	36.25	2.09	0.93	1.39	3.02	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	192.36	26.67	35.21	5.44	1.29	16.57	5.44	8.80
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	220.94	22.21	145.25	7.60	2.63	23.96	17.24	12.86
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	112.47	33.00	78.08	5.58	1.39	17.20	3.25	5.11
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	190.00	25.09	86.77	5.76	4.94	19.33	4.11	7.40
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	32.23	23.02	32.23	2.15	5.22	31.62	0.92	15.35
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	194.58	49.07	55.90	4.27	7.68	15.36	1.28	9.81
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	238.09	54.90	60.36	4.55	6.07	17.89	0.91	12.74
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	262.13	57.29	74.86	5.05	7.46	16.61	1.68	10.83
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	128.52	22.05	63.04	3.56	4.01	10.91	6.24	8.02
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	69.38	11.67	23.68	3.67	3.00	3.67	1.67	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	44.60	22.30	89.19	5.57	13.01	3.72	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	45.95	10.92	68.55	1.51	1.88	3.39	2.64	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	116.01	19.63	72.40	6.11	3.93	6.11	1.74	6.11
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	76.85	44.99	146.21	7.50	13.12	11.25	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	18.13	14.13	0.00	0.94	0.00	0.24	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	17.84	8.07	2.64	0.16	0.31	0.00	0.00	0.00
adipose, donor1	10184-103D4	26.39	22.87	2.35	2.93	1.17	1.17	0.59	0.00
adipose, donor2	10185-103D5	5.27	4.87	0.00	0.41	0.00	0.00	0.81	0.00
adipose, donor3	10186-103D6	9.53	5.72	0.82	0.54	0.27	0.00	0.00	0.00
adipose, donor4	10187-103D7	6.93	3.47	0.87	0.00	0.00	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	8.68	12.31	8.21	0.63	1.58	0.47	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	10.91	14.55	0.00	0.00	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	20.28	9.74	1.33	0.53	0.27	0.13	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	39.66	7.86	11.08	0.36	1.07	1.79	0.36	0.71
amniotic membrane cells, donor1	12235-129G3	13.68	17.39	0.46	0.23	0.00	0.00	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	62.89	38.88	1.35	2.37	0.00	0.00	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	14.73	14.44	0.00	0.29	0.00	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	13.04	5.93	3.56	0.00	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	15.61	15.21	8.72	1.01	0.61	0.00	0.20	0.20
amygdala, newborn, donor10223	10360-105E9	18.08	3.23	10.33	2.90	0.65	0.00	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	21.90	9.93	2.80	0.13	0.51	0.13	0.38	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	19.41	8.16	1.54	0.66	0.22	4.41	0.66	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	12.36	5.01	3.67	5.68	0.00	0.00	0.67	0.33
aorta, adult, pool1	10052-101G7	19.22	13.93	3.92	0.00	0.59	0.00	0.20	0.20
appendix, adult	10189-103D9	15.91	8.54	11.26	0.00	1.94	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	37.14	13.41	9.63	4.13	1.03	0.00	0.00	0.34
artery, adult	10190-103E1	13.59	4.08	1.36	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	19.70	5.65	15.21	0.29	1.01	1.16	0.14	0.29
b cell line:RPMI1788	10427-106D4	13.98	12.49	7.29	0.89	0.89	0.15	0.59	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	43.56	28.02	6.94	0.55	1.66	0.00	1.11	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	9.82	4.47	0.40	0.60	0.10	0.30	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	1.84	1.00	0.17	0.33	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	75.50	29.64	36.35	2.80	2.80	10.07	1.68	4.47
bladder, adult, pool1	10011-101C2	26.51	12.93	4.13	0.11	0.11	0.11	0.00	0.11
blood, adult, pool1	10053-101G8	8.86	2.21	6.64	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	31.68	16.27	2.57	0.00	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	25.64	8.10	8.10	0.00	1.35	0.00	2.02	0.00
brain, adult, donor1	10084-102B3	3.08	5.13	2.05	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	10.80	7.35	3.56	0.00	1.34	0.11	0.33	0.00
brain, fetal, pool1	10085-102B4	0.00	8.01	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	62.44	18.17	4.96	4.96	0.66	0.00	1.32	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	67.03	14.10	5.49	2.50	0.12	0.12	0.25	0.00
breast, adult, donor1	10080-102A8	12.00	12.63	3.16	0.00	1.26	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	12.20	5.08	0.51	0.38	0.13	0.25	0.38	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	5.26	5.26	0.31	0.00	0.00	0.31	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	24.63	14.50	6.45	0.69	0.92	0.23	1.38	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	6.54	2.42	0.73	0.24	0.00	0.24	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	34.32	18.81	19.28	3.76	0.47	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	57.21	17.17	11.27	5.80	0.88	1.42	0.33	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	8.87	6.34	6.34	0.63	0.00	0.00	0.63	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	37.26	17.30	28.21	0.53	2.66	0.00	2.93	0.00
caudate nucleus - adult, donor10196	10177-103C6	14.97	14.97	9.21	0.00	2.30	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	18.57	20.25	10.21	0.84	1.00	0.33	0.50	0.00
caudate nucleus, adult, donor10258	10379-105H1	13.75	14.52	11.46	1.53	0.76	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	10.62	4.03	20.51	1.83	0.73	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	26.22	17.48	26.22	0.00	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	30.53	26.26	10.25	0.21	1.92	0.21	1.49	0.21
cerebellum, adult, pool1	10083-102B2	8.62	7.59	1.72	1.38	0.34	0.34	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	13.28	0.83	14.95	1.66	0.00	0.00	1.66	0.00
cerebral meninges, adult	10188-103D8	11.60	7.82	4.29	0.00	0.25	0.25	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	5.12	2.19	0.73	0.00	0.73	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	14.52	5.46	4.31	1.87	0.29	0.00	0.29	0.00
cervical cancer cell line:ME-180	10553-107I4	29.83	12.43	4.14	1.16	0.00	1.66	0.00	0.50
cervix, adult, pool1	10013-101C4	46.09	21.10	8.29	0.52	0.73	0.31	1.26	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	33.30	20.06	3.20	1.11	0.00	0.14	0.14	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	13.06	3.92	1.31	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	59.03	10.56	4.10	6.84	0.37	0.00	0.99	0.00
choriocarcinoma cell line:SCH	10785-110H2	13.06	3.20	1.36	2.22	0.25	0.00	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	16.13	6.40	0.47	1.42	0.00	0.24	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	37.61	29.63	0.57	1.14	0.85	0.00	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	47.93	38.38	3.18	1.19	0.50	0.10	0.80	0.10
chorionic membrane cells, donor3	12240-129G8	73.63	56.60	1.10	2.20	0.00	0.00	3.85	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	253.46	26.25	206.00	16.16	5.05	22.22	11.11	17.17
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	92.98	30.74	26.51	3.07	1.34	4.42	1.34	2.50
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	51.74	26.40	40.34	2.11	3.38	5.28	1.06	2.75
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	17.98	9.24	5.14	0.51	0.51	0.51	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	16.93	8.95	8.22	0.00	1.94	0.48	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	19.14	13.23	9.57	0.61	2.04	1.63	0.61	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	17.08	7.36	4.12	0.59	0.29	1.18	0.59	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	111.81	31.01	46.91	1.56	2.09	8.08	0.52	4.95
clear cell carcinoma cell line:JHOC-5	10638-108I8	11.66	10.06	3.43	0.46	0.69	0.23	0.69	0.00
clear cell carcinoma cell line:TEN	10636-108I6	18.04	8.85	1.56	0.69	0.17	0.52	0.69	0.00
colon carcinoma cell line:CACO-2	10513-107D9	21.42	5.86	3.84	2.01	0.37	0.00	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	81.34	17.86	42.57	6.08	3.04	0.38	0.76	0.00
colon, adult, donor1	10082-102B1	8.33	5.95	2.38	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	16.33	7.99	2.94	0.35	0.59	0.12	0.00	0.00
colon, fetal, donor1	10070-101I7	9.89	8.03	11.12	0.00	0.62	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	77.92	18.33	142.09	0.00	4.58	13.75	0.00	9.17
common myeloid progenitor CMP, donor2	12134-128E1	100.15	25.04	100.15	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	62.04	12.32	26.35	2.55	3.82	6.37	0.00	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	96.60	12.38	45.58	2.41	1.66	3.92	0.60	1.21
cord blood derived cell line:COBL-a untreated	10449-106F8	114.08	19.74	55.98	4.65	2.12	8.32	0.42	1.13
corpus callosum, adult, pool1	10042-101F6	6.30	5.86	5.31	0.44	0.77	0.11	0.11	0.00
cruciate ligament, donor2	10295-104G7	8.10	7.29	1.62	0.00	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	13.64	12.84	4.01	0.80	2.41	0.80	0.80	0.00
diencephalon, adult	10193-103E4	10.08	8.40	6.72	0.24	0.24	0.00	0.96	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	5.97	3.21	2.76	0.00	0.00	0.23	0.46	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	34.88	6.15	3.85	2.56	0.77	0.77	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	58.01	12.28	17.09	1.44	1.69	0.24	0.24	0.00
ductus deferens, adult	10196-103E7	231.73	50.33	41.36	8.47	5.48	0.00	5.48	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	50.41	11.52	23.04	2.88	2.88	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	67.68	16.92	34.58	5.15	1.47	0.74	7.36	0.00
dura mater, adult, donor1	10041-101F5	40.96	16.93	6.52	0.91	1.32	0.17	0.50	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	23.54	2.44	7.33	1.33	0.00	1.55	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	37.54	5.30	5.02	2.15	0.43	0.29	0.14	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	4.32	2.47	2.47	0.00	1.85	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	3.63	2.72	0.30	0.00	0.30	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	2.16	3.70	0.93	0.31	0.93	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	1.31	2.63	0.00	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	17.09	2.35	7.04	1.34	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	38.42	25.92	23.74	0.72	2.72	0.36	3.62	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	10.94	5.63	1.45	0.80	0.16	0.00	0.48	0.00
epidermoid carcinoma cell line:A431	10426-106D3	34.35	14.90	0.78	0.44	0.00	0.67	0.22	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	12.65	6.49	0.11	0.44	0.11	0.11	0.00	0.00
epididymis, adult	10197-103E8	95.66	27.42	12.14	3.77	1.05	0.21	1.88	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	59.25	15.79	24.31	2.31	4.08	0.53	2.13	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	76.29	12.98	19.66	3.93	0.39	0.00	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	17.69	9.04	1.05	0.26	0.00	0.92	0.66	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	14.57	11.61	1.67	0.89	0.10	0.69	0.59	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	14.23	10.53	1.57	0.56	0.00	1.01	0.78	0.34
esophagus, adult, pool1	10015-101C6	53.62	14.02	3.29	2.44	0.32	0.00	0.32	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	41.08	12.65	11.65	1.50	1.13	0.13	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	19.32	7.24	0.00	0.00	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	8.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	1.49	1.49	0.00	0.00	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	9.17	2.29	9.17	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	7.29	1.46	5.83	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	27.20	17.03	15.51	1.53	1.27	0.00	1.78	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	10.64	7.05	1.15	0.77	0.38	0.64	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	14.96	11.16	4.27	0.24	0.71	0.47	1.19	0.00
frontal lobe, adult, pool1	10040-101F4	13.79	11.82	5.44	0.66	0.75	0.09	0.28	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	19.22	10.81	0.30	0.60	0.60	0.60	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	52.12	26.70	2.29	1.19	0.55	0.37	0.55	0.46
gall bladder, adult	10198-103E9	14.24	6.52	3.14	0.00	0.00	0.24	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	33.28	10.74	8.05	0.54	0.54	0.00	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	36.23	6.35	6.72	0.37	0.00	0.75	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	5.91	2.32	2.11	0.84	0.21	0.00	1.27	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	11.60	4.06	0.97	0.97	0.00	0.19	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	28.36	22.46	21.64	2.30	2.62	0.49	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	21.97	11.90	3.66	3.66	0.00	0.00	2.75	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	43.18	9.82	18.05	3.20	0.23	0.23	3.66	0.23
giant cell carcinoma cell line:LU65	10487-107B1	1.15	0.11	0.23	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	14.84	7.00	2.94	1.12	0.28	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.23	6.73	1.50	0.25	0.00	0.25	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	25.23	14.88	13.62	0.84	0.84	0.21	0.21	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	30.05	18.54	11.38	1.40	2.25	0.28	0.56	0.28
glioblastoma cell line:T98G	10485-107A8	38.52	12.25	4.97	0.44	0.44	0.11	0.11	0.44
glioma cell line:GI-1	10413-106B8	43.35	16.40	21.67	0.88	1.76	0.59	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	8.75	7.29	10.20	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	19.04	15.38	8.30	0.49	0.49	0.00	0.73	0.00
globus pallidus, adult, donor10258	10367-105F7	12.32	6.85	6.85	0.00	0.00	1.37	4.11	1.37
globus pallidus, newborn, donor10223	10364-105F4	10.66	3.73	13.86	0.00	0.53	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	24.47	95.44	2.45	7.34	12.24	0.00	14.68
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	120.21	10.93	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	5.23	41.81	0.00	5.23	5.23	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	15.68	6.72	5.76	0.32	0.64	0.32	1.92	0.00
hIPS +CCl2, biol_rep1	14383-156B9	11.02	5.05	1.84	3.21	0.00	0.46	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	16.92	5.03	1.37	2.74	0.00	0.00	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	7.73	1.29	2.58	1.29	0.00	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	10.06	1.44	8.62	2.87	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	15.77	0.00	2.06	0.69	0.00	1.37	0.00	0.00
hIPS, biol_rep3	14382-156B8	14.35	6.62	8.83	1.10	1.10	0.00	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.86	2.01	0.00	0.00	0.00	1.15	0.00	0.29
heart - mitral valve, adult	10205-103F7	42.75	25.11	12.26	0.00	0.90	0.00	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	29.02	13.60	6.01	0.00	0.78	0.00	1.57	0.00
heart - tricuspid valve, adult	10207-103F9	41.63	29.14	4.16	0.00	2.50	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	7.35	7.14	2.04	0.61	0.00	0.20	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	7.24	5.54	1.28	0.00	0.43	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	12.65	9.89	2.76	0.00	0.46	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	23.41	11.91	20.64	0.82	1.44	0.31	0.31	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	52.14	31.78	8.95	1.23	2.47	0.62	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	17.84	4.76	1.19	3.57	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	29.39	10.61	8.62	2.10	0.33	0.44	0.44	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	31.80	11.89	7.77	1.21	0.36	0.24	1.70	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	36.99	10.71	6.47	1.92	0.40	0.00	0.71	0.00
hepatoma cell line:Li-7	10484-107A7	29.36	4.67	3.34	3.23	0.11	0.33	0.33	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	6.73	4.52	3.62	0.90	0.40	0.10	0.00	0.10
hippocampus - adult, donor10196	10169-103B7	12.30	12.30	1.89	0.00	4.73	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	13.88	14.70	7.55	0.41	0.20	0.00	0.61	0.20
hippocampus, adult, donor10258	10374-105G5	8.47	4.48	5.98	1.99	1.00	0.00	3.49	0.00
hippocampus, newborn, donor10223	10363-105F3	5.29	3.88	10.57	0.70	1.06	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	9.16	3.05	1.22	1.83	0.00	0.00	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	3.14	1.37	0.98	0.59	0.00	0.00	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4.82	1.78	0.76	1.27	0.51	0.00	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	6.77	2.26	1.13	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	11.62	5.42	0.77	1.81	0.00	0.00	1.55	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	12.15	2.66	0.76	0.38	0.00	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	10.51	2.63	1.46	2.04	0.00	0.29	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	16.16	6.89	1.51	1.29	0.00	0.00	0.86	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	11.26	5.00	2.92	1.25	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	15.39	4.50	4.03	0.95	0.24	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	14.14	4.34	0.80	0.48	0.48	0.00	0.48	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	14.81	7.41	2.69	2.02	0.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	4.38	1.25	0.31	0.63	0.00	0.16	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	7.37	1.97	0.49	0.49	0.00	0.00	1.97	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.98	1.75	1.75	1.75	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	14.89	6.87	2.10	1.53	0.00	0.19	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	12.65	6.54	1.74	2.62	0.44	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	14.99	6.50	1.00	2.50	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	10.74	5.46	1.51	0.94	0.00	0.00	0.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	11.82	8.64	2.73	1.82	0.00	0.00	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.77	4.39	2.82	2.19	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.76	4.57	2.94	0.82	0.00	0.16	0.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.93	6.10	1.45	1.16	0.00	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.36	4.78	0.90	1.20	0.00	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	6.65	3.69	1.66	0.18	0.00	0.18	0.37	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	6.85	1.71	1.14	2.00	0.00	0.00	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	8.17	2.04	0.82	2.86	0.00	0.00	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	20.42	6.69	3.52	2.11	0.35	0.00	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	14.25	7.92	0.95	1.58	0.00	0.00	1.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	12.71	2.72	3.33	1.82	0.00	0.30	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	11.89	7.24	4.65	1.55	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.93	5.98	1.99	1.33	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.85	4.62	3.33	1.03	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.11	6.39	3.83	0.77	0.26	0.00	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	21.96	8.33	5.30	0.00	0.00	0.00	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	13.44	4.37	2.35	1.01	0.34	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.42	2.17	0.72	1.21	0.00	0.24	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	7.13	0.89	1.34	1.34	0.00	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	7.80	1.95	2.44	0.49	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	16.20	3.97	1.83	4.28	0.00	0.00	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	120.37	19.52	0.00	26.03	0.00	0.00	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	21.51	7.61	1.32	3.97	0.33	0.00	0.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	22.99	8.21	3.83	0.55	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	16.28	2.90	2.53	2.53	0.36	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	12.10	4.63	1.78	1.42	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	2.39	2.39	2.39	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	21.94	10.29	3.25	2.30	0.41	0.27	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.43	1.62	3.50	1.89	0.00	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	29.30	5.33	1.70	2.18	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	5.54	2.38	0.79	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	5.68	5.02	1.70	0.09	0.57	0.00	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	9.10	6.50	0.00	0.00	0.00	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	28.54	8.31	4.01	1.10	0.60	0.10	0.50	0.00
kidney, fetal, pool1	10045-101F9	5.38	2.26	1.84	0.42	0.28	0.00	0.07	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	4.83	1.42	2.41	0.43	0.28	0.28	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.05	9.40	4.42	1.94	0.28	0.14	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	8.62	4.59	1.83	0.55	0.37	1.10	0.18	0.55
left atrium, adult, donor1	10079-102A7	22.34	20.70	11.99	0.00	1.63	0.00	0.54	0.54
left ventricle, adult, donor1	10078-102A6	19.72	10.11	4.55	1.01	1.01	0.00	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	22.71	14.23	4.65	0.55	1.09	0.00	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	20.84	9.34	5.39	1.44	0.36	0.00	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	16.85	7.07	2.17	1.09	1.09	0.54	1.09	0.00
leiomyoma cell line:15425	10571-108B4	39.34	15.54	8.74	0.97	1.46	0.49	2.67	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	19.05	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	18.82	5.23	1.05	0.00	0.00	2.09	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	25.26	8.38	12.75	1.18	0.59	1.30	0.94	0.24
liposarcoma cell line:KMLS-1	10782-110G8	46.24	19.53	6.72	0.78	0.94	2.50	1.41	0.47
liposarcoma cell line:SW 872	10726-110A6	29.36	16.45	4.63	1.83	0.49	1.10	0.73	0.37
liver, adult, pool1	10018-101C9	107.28	26.58	23.34	1.46	1.30	0.32	0.65	0.00
liver, fetal, pool1	10086-102B5	15.05	10.35	6.58	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	5.83	5.69	3.21	0.00	0.44	0.15	0.29	0.00
locus coeruleus, adult, donor10252	10165-103B3	13.84	14.95	5.72	0.18	0.55	0.00	0.55	0.00
locus coeruleus, adult, donor10258	10375-105G6	8.18	9.03	5.64	1.13	0.28	0.00	0.56	0.28
locus coeruleus, newborn, donor10223	10362-105F2	22.71	4.63	15.14	0.84	0.00	0.00	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	107.95	31.42	53.97	8.86	6.23	0.00	0.69	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	4.14	6.89	0.00	0.69	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	31.11	12.00	2.11	3.30	0.66	0.53	0.26	0.66
lung, adult, pool1	10019-101D1	30.36	17.13	6.50	0.83	0.24	0.00	0.12	0.35
lung, fetal, donor1	10068-101I5	93.33	28.83	24.55	1.43	1.14	0.57	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	29.33	16.04	2.75	1.37	0.46	0.00	3.21	0.00
lymph node, adult, donor1	10077-102A5	18.46	9.94	10.89	0.00	1.42	0.47	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	7.89	9.42	2.63	0.44	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	5.28	3.77	8.90	0.15	1.06	0.15	0.00	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	16.14	3.40	1.70	0.00	0.85	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	9.77	7.99	1.78	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	7.68	8.92	2.28	0.42	0.21	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	8.30	12.33	2.13	0.24	0.24	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	9.74	5.00	3.69	0.26	0.26	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	82.20	16.44	27.64	5.72	3.34	0.24	0.95	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	7.90	6.77	1.13	1.13	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	15.63	12.87	3.86	0.18	0.18	0.00	1.47	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	10.17	5.08	1.91	0.64	0.32	0.00	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	21.75	6.40	19.62	2.56	1.71	0.00	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	7.93	8.94	4.22	0.68	0.34	0.00	2.36	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	15.07	10.19	3.61	0.00	0.64	0.21	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	1.93	11.56	0.00	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	43.06	14.35	0.00	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	10.77	4.67	8.26	0.72	1.79	0.36	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	16.22	21.42	11.68	1.95	2.60	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	26.63	20.43	10.37	0.77	0.31	0.15	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	5.47	3.92	1.96	0.08	0.82	0.16	0.16	0.00
medulla oblongata, newborn, donor10223	10361-105F1	7.64	3.47	7.64	0.69	0.35	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	21.03	5.76	5.76	2.21	0.44	0.22	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	8.80	7.34	1.10	0.37	0.24	0.00	0.37	0.00
melanoma cell line:COLO 679	10514-107E1	10.92	4.74	1.58	0.29	0.29	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	4.61	6.24	1.09	0.54	0.00	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	34.01	13.75	2.89	1.09	0.00	0.36	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	25.55	6.17	26.43	0.88	0.00	0.00	3.52	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	9.59	1.56	2.85	0.26	0.00	0.26	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.60	25.16	7.21	0.92	0.77	0.31	0.77	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	71.99	33.08	15.09	1.45	0.73	0.00	1.45	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	39.75	20.71	7.45	0.83	0.83	0.41	0.83	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	37.51	29.64	7.45	0.42	0.98	0.28	1.40	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	47.18	43.71	9.82	1.35	0.39	0.77	0.96	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	44.42	24.29	11.80	0.69	0.69	3.47	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	186.22	74.32	87.88	9.44	4.63	0.34	2.92	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	36.81	26.68	6.10	1.27	0.46	0.46	1.04	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	34.35	30.64	7.96	0.80	1.06	0.53	0.66	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	52.13	31.60	11.88	2.97	1.89	0.27	0.95	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	48.08	30.30	13.51	0.43	2.13	0.85	1.56	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	112.31	29.97	23.71	3.29	1.32	0.00	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	34.04	28.37	6.50	0.42	0.97	0.28	0.83	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	84.13	20.94	16.41	1.05	1.05	1.05	2.79	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	36.95	31.65	3.47	0.61	0.82	0.41	1.22	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	42.42	10.78	4.67	1.80	0.00	0.36	1.44	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	40.24	36.41	6.31	0.41	1.03	1.03	1.14	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	24.40	10.26	4.10	0.68	0.00	0.00	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	53.70	27.69	16.78	1.26	2.52	0.00	1.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.81	24.66	4.18	0.30	0.15	0.60	1.05	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	43.50	26.26	11.64	0.88	1.23	0.26	0.96	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	60.75	29.08	23.19	0.74	2.21	0.37	2.21	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.18	15.74	1.72	0.00	0.57	0.00	1.14	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	29.05	10.95	2.95	1.26	0.84	1.26	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.92	19.18	4.11	0.00	0.00	1.83	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.56	13.56	2.05	0.00	0.51	0.26	1.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	22.51	15.18	2.62	1.05	0.52	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	22.18	13.25	3.08	0.62	0.00	0.00	1.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.60	14.83	3.53	0.24	0.94	0.24	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	30.12	18.95	5.08	0.34	0.68	0.34	1.02	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.54	15.33	3.14	0.39	0.79	0.39	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.24	9.27	1.39	0.00	0.46	0.00	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	36.34	16.15	2.60	0.29	0.58	0.29	1.44	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	25.66	15.39	1.34	0.22	0.67	0.22	0.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	32.45	16.58	4.09	0.24	0.48	0.96	1.20	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.80	22.00	5.13	0.00	1.47	0.73	1.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	19.13	12.42	2.01	0.00	0.00	1.68	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	22.93	11.46	5.73	0.00	0.00	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	23.20	14.60	3.44	0.43	0.43	0.43	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	13.67	0.00	0.00	0.00	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.44	10.07	2.60	0.32	0.32	1.30	0.97	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	33.46	10.18	1.45	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	24.52	12.26	1.60	0.00	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	9.00	2.45	0.00	0.82	0.00	2.45	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	21.38	12.83	2.33	0.39	0.78	0.39	2.33	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	10.49	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	6.95	6.95	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	14.30	4.77	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	24.31	10.08	5.93	0.00	1.78	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	20.71	2.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	39.90	14.57	2.53	0.63	0.00	0.63	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	25.52	15.52	2.41	0.00	0.34	0.34	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	10.75	0.00	0.00	2.15	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	3.99	0.00	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	3.44	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	26.08	13.04	5.30	0.41	0.41	0.00	1.22	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	26.22	15.09	4.77	0.79	0.00	0.00	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.15	8.25	1.18	0.00	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.34	10.29	1.56	0.00	0.31	0.00	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	8.02	2.67	1.34	0.00	0.00	5.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	7.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	5.14	5.14	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.95	7.57	4.82	0.00	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	5.94	5.44	3.46	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	7.85	4.49	1.12	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	4.45	3.82	3.18	0.64	0.00	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	3.63	2.42	2.82	0.00	0.40	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	4.36	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	1.27	3.80	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.38	12.74	33.99	0.00	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	13.56	31.63	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	26.36	9.06	30.48	1.65	2.47	0.00	6.59	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	18.06	8.33	4.96	0.40	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.33	10.06	2.60	0.32	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	13.24	6.11	7.13	0.00	0.00	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	19.34	5.42	6.19	0.00	1.55	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	27.40	18.19	7.80	0.24	0.94	0.24	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	84.79	23.63	32.43	4.87	3.94	0.23	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	8.55	0.00	0.00	0.00	0.00	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	33.80	12.84	1.13	0.62	0.21	0.31	1.64	0.00
mesothelioma cell line:Mero-25	10850-111F4	8.85	0.91	4.77	1.36	0.00	0.00	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	45.23	12.96	10.51	1.22	0.49	0.24	2.69	0.00
mesothelioma cell line:Mero-48a	10852-111F6	19.71	5.76	2.44	0.44	0.44	0.00	1.55	0.00
mesothelioma cell line:Mero-82	10853-111F7	17.08	5.78	3.15	0.26	0.00	0.79	2.10	0.00
mesothelioma cell line:Mero-83	10854-111F8	30.98	10.21	4.60	2.89	0.00	0.17	1.36	0.00
mesothelioma cell line:Mero-84	10855-111F9	5.31	1.77	1.26	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	21.53	4.97	6.42	0.21	0.83	0.00	1.04	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	27.99	8.94	6.79	1.49	0.50	0.17	1.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	37.65	6.15	7.96	3.98	1.27	0.72	1.81	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	44.24	15.37	7.35	2.39	0.51	0.00	1.37	0.00
mesothelioma cell line:NCI-H28	10845-111E8	1.02	2.54	1.02	0.25	0.00	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	8.48	2.28	0.33	0.00	0.00	0.33	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	28.72	6.77	0.81	0.81	0.00	0.54	1.63	0.00
migratory langerhans cells, donor1	11901-125F2	1.73	0.77	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	0.61	1.10	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	3.05	2.69	0.18	0.00	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	30.04	9.14	6.53	0.98	0.98	0.98	2.94	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.27	6.36	0.21	0.42	0.21	0.85	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	32.94	18.66	2.30	0.92	0.46	0.69	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	3.62	1.71	1.33	0.00	0.00	0.95	0.00	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	148.39	35.85	50.82	3.33	2.40	9.05	0.74	6.47
myeloma cell line:PCM6	10474-106I6	7.51	4.94	0.79	0.40	0.00	0.00	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	3.55	4.57	4.06	0.00	0.51	1.01	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	22.56	17.46	0.59	0.00	0.00	0.39	0.78	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	33.43	11.92	1.67	0.67	0.11	0.00	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	37.73	8.90	1.99	1.32	0.29	0.00	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	22.63	5.52	0.55	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	18.40	10.12	7.82	1.38	0.00	0.23	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	28.81	13.84	15.15	1.87	0.56	0.00	0.19	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	62.84	16.24	35.64	6.75	1.69	0.00	2.11	0.00
neuroblastoma cell line:NH-12	10555-107I6	12.30	7.45	8.39	0.37	0.37	0.00	0.75	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	7.83	4.51	10.44	0.00	0.24	0.00	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	4.91	2.53	5.07	0.16	0.48	0.00	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	8.05	6.04	5.03	0.00	0.20	0.00	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	4.45	10.81	6.99	1.91	2.54	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	30.61	10.91	3.46	0.00	0.53	0.00	0.27	0.27
neutrophil PMN, donor1	12133-128D9	29.75	14.87	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	18.94	0.00	0.00	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	419.25	125.15	299.34	9.13	17.59	5.75	4.57	8.79
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	88.86	18.41	24.82	4.00	4.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	74.06	45.53	21.16	2.24	2.24	0.32	1.92	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	27.85	12.35	7.88	0.79	1.31	0.00	0.79	0.00
nucleus accumbens, adult, pool1	10037-101F1	10.31	8.81	5.91	0.56	0.47	0.09	0.19	0.00
occipital cortex - adult, donor10196	10172-103C1	22.66	6.18	12.36	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	15.30	12.61	6.44	0.54	0.27	0.00	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	9.46	3.64	9.46	1.82	1.46	0.00	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	5.77	10.76	4.46	0.00	1.57	0.00	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	10.73	20.17	21.03	0.43	1.29	0.00	1.29	0.00
occipital pole, adult, pool1	10036-101E9	1.81	2.92	1.02	0.08	0.16	0.08	0.00	0.00
olfactory region, adult	10195-103E6	9.36	11.08	5.16	0.19	0.19	0.19	0.57	0.00
optic nerve, donor1	10277-104E7	12.01	18.01	2.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	57.64	9.45	8.32	2.85	0.34	0.23	0.34	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	23.63	8.79	1.37	1.65	0.14	0.00	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	9.65	3.22	0.34	0.00	0.00	0.00	0.51	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	3.58	2.19	0.12	0.46	0.00	0.00	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	28.51	14.40	3.82	0.59	0.29	0.88	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	18.69	4.67	2.80	1.87	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	45.80	14.42	5.73	1.48	0.64	0.21	0.21	0.42
ovary, adult, pool1	10020-101D2	34.24	14.50	7.34	1.05	0.35	0.35	0.26	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	83.41	25.66	6.78	3.85	1.83	6.78	2.57	2.02
pancreas, adult, donor1	10049-101G4	161.79	48.91	55.50	29.16	0.94	0.00	4.70	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	11.46	3.35	0.28	0.56	0.00	0.00	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	20.61	9.88	1.70	0.34	0.17	0.51	1.19	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	10.60	3.64	0.99	0.17	0.00	0.00	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	6.77	6.41	2.29	0.18	0.64	0.09	0.27	0.00
parietal cortex, adult, donor10258	10373-105G4	11.74	9.54	6.61	0.00	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	13.17	8.46	7.52	0.94	0.00	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	9.41	11.40	4.85	0.29	0.29	0.00	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	4.93	4.85	1.85	0.35	0.53	0.00	0.18	0.00
parietal lobe, fetal, donor1	10072-101I9	20.37	19.40	19.40	0.00	5.82	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	14.21	1.12	15.33	0.75	0.37	0.00	0.75	0.00
parotid gland, adult	10199-103F1	359.52	69.07	270.72	26.52	19.12	0.00	7.40	0.00
penis, adult	10200-103F2	17.72	8.06	1.61	0.00	0.54	0.54	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	19.15	3.35	6.32	0.93	0.37	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	18.94	6.41	2.48	0.58	0.87	0.00	0.87	0.00
pineal gland - adult, donor10196	10179-103C8	32.25	25.16	14.19	2.58	0.65	0.65	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	63.37	47.97	19.54	2.37	2.96	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	18.81	19.44	13.80	1.25	0.00	1.88	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	159.86	50.59	115.35	15.18	13.15	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	287.17	106.84	125.60	16.68	15.11	0.52	7.30	0.00
pituitary gland, adult, donor10258	10378-105G9	138.75	51.07	52.78	7.66	3.40	0.00	8.51	0.00
placenta, adult, pool1	10021-101D3	87.08	40.31	3.12	2.69	0.22	0.22	0.75	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	12.58	6.49	6.62	1.06	0.13	0.53	0.26	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.80	22.88	2.65	0.47	0.31	0.47	0.62	0.16
pons, adult, pool1	10033-101E6	13.08	9.98	5.42	0.34	0.34	0.00	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	2.18	3.75	1.39	0.09	0.35	0.00	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	20.91	12.55	92.02	2.09	18.82	23.01	0.00	54.38
promyelocytes/myelocytes PMC, donor2	12136-128E3	291.93	33.05	242.35	11.02	11.02	11.02	0.00	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	140.83	35.21	129.09	11.74	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	8.16	6.12	0.87	0.44	0.58	0.44	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	25.23	9.80	4.72	0.91	0.36	0.00	0.36	0.00
prostate, adult, pool1	10022-101D4	32.20	13.69	6.26	0.82	0.54	0.09	0.63	0.27
putamen, adult, donor10196	10176-103C5	12.75	20.77	12.04	0.71	2.12	0.00	1.18	0.00
putamen, adult, donor10252	10152-102I8	23.53	11.76	9.80	0.00	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	8.74	2.19	7.65	2.19	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	16.91	11.11	7.25	0.24	2.17	0.24	1.21	0.00
putamen, newborn, donor10223	10365-105F5	14.99	0.75	22.49	0.00	3.00	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	21.82	7.27	2.04	1.75	0.00	0.00	0.58	0.00
rectum, fetal, donor1	10067-101I4	13.91	34.77	19.47	0.00	5.56	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	42.19	20.99	1.70	1.06	0.85	0.21	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	22.78	11.60	9.11	0.00	0.00	0.00	2.07	0.41
retina, adult, pool1	10030-101E3	12.72	7.36	5.17	0.30	0.50	0.10	0.20	0.00
retinoblastoma cell line:Y79	10475-106I7	20.52	13.25	7.79	2.34	0.26	0.26	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	18.57	10.70	3.93	1.11	0.25	0.00	0.37	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	10.40	6.19	6.19	0.00	0.28	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	38.65	16.67	8.34	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	11.98	7.28	0.81	0.81	0.00	0.00	0.32	0.00
salivary acinar cells, donor2	11772-123I8	7.57	3.17	0.69	0.00	0.14	0.00	0.28	0.14
salivary acinar cells, donor3	11773-123I9	3.97	1.99	1.32	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	215.05	46.33	115.53	38.32	6.29	1.14	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.88	4.30	1.85	0.42	0.17	0.59	0.42	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	11.17	7.99	2.23	0.59	0.24	0.24	0.24	0.00
seminal vesicle, adult	10201-103F3	308.98	66.66	50.79	9.52	6.35	0.00	10.58	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.71	3.40	3.16	0.00	0.00	0.97	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.33	6.79	2.26	0.00	0.00	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	19.07	6.02	1.00	1.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	7.52	4.03	0.27	0.67	0.13	0.13	0.54	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	18.57	6.52	0.55	0.33	0.22	0.88	0.11	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	5.29	3.87	0.26	0.52	0.00	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	3.55	1.42	0.71	0.00	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	11.99	5.76	1.44	0.00	0.12	0.12	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	4.02	7.04	4.02	0.00	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	33.93	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	20.20	24.62	13.89	0.00	1.89	0.63	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	33.02	8.67	17.68	3.00	2.00	0.67	0.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	41.61	6.62	13.24	5.04	0.63	0.00	1.58	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	6.17	7.52	16.77	0.77	2.89	0.19	0.58	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	8.57	4.29	0.49	0.33	0.00	0.00	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	25.25	8.36	6.11	4.02	0.16	0.00	0.64	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	83.03	18.74	45.76	11.77	1.74	0.87	1.74	0.00
small intestine, adult, pool1	10024-101D6	19.47	8.96	4.06	0.24	0.12	0.00	0.12	0.00
small intestine, fetal, donor1	10064-101I1	9.09	7.62	5.41	0.25	0.49	0.25	0.74	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	151.31	26.67	13.85	10.26	2.05	0.00	5.64	0.51
smooth muscle, adult, pool1	10048-101G3	20.16	14.47	2.58	0.26	0.26	0.00	1.29	0.00
somatostatinoma cell line:QGP-1	10781-110G7	93.27	13.94	25.46	10.45	4.02	0.00	1.88	0.00
spinal cord - adult, donor10196	10181-103D1	10.55	8.26	6.42	0.23	0.46	0.00	2.29	0.00
spinal cord, adult, donor10252	10159-103A6	20.50	14.59	9.46	0.00	1.18	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	17.29	11.07	15.22	0.69	0.69	0.00	2.77	0.00
spinal cord, fetal, donor1	10056-101H2	24.39	10.37	9.15	0.00	0.61	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	12.86	1.84	11.48	0.46	0.92	0.00	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	41.52	27.33	4.63	0.75	0.90	0.45	0.60	0.30
spleen, adult, pool1	10025-101D7	22.25	7.71	5.62	0.55	0.22	0.22	0.11	0.00
spleen, fetal, pool1	10044-101F8	8.74	3.97	5.32	0.32	0.56	0.24	0.08	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1.97	1.86	0.41	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	25.44	11.96	1.33	1.14	0.19	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	10.83	8.39	1.40	0.70	0.00	0.35	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	10.95	4.30	1.56	0.00	0.00	0.39	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	2.93	0.68	0.11	0.11	0.00	0.11	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	22.45	10.17	2.97	0.85	1.69	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	11.00	3.38	5.08	0.00	0.00	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	28.84	17.09	10.68	3.20	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	432.96	89.44	252.37	23.93	18.23	0.00	10.25	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	10.59	9.97	3.74	0.42	0.21	0.00	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	10.35	8.79	8.28	2.07	0.52	0.00	2.07	0.00
substantia nigra, newborn, donor10223	10358-105E7	8.48	0.71	5.65	0.71	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	7.34	5.27	6.65	0.23	0.69	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	2.03	1.86	1.36	0.08	0.42	0.00	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	13.53	17.81	12.11	0.00	0.71	0.00	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	15.82	8.35	14.50	2.20	0.88	0.44	1.32	0.00
tenocyte, donor1	11763-123H8	56.21	40.50	6.98	0.00	0.35	0.35	4.19	0.00
tenocyte, donor2	11765-123I1	44.64	28.23	4.96	0.38	0.00	1.14	4.58	0.38
tenocyte, donor3	11768-123I4	43.00	26.69	4.45	1.11	1.11	0.74	1.85	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	2.72	2.04	0.68	0.17	0.00	0.00	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	8.02	7.24	4.01	0.92	0.00	0.31	0.15	0.00
teratocarcinoma cell line:PA-1	10807-111A6	10.23	7.13	1.86	0.31	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	20.18	6.09	0.63	3.17	0.00	0.00	0.38	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	5.67	1.89	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.76	1.64	0.11	0.33	0.11	0.00	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	7.49	1.63	1.30	0.33	0.00	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	44.56	20.29	16.86	1.83	1.18	1.07	1.07	0.97
testis, adult, pool2	10096-102C6	30.67	14.43	15.79	1.80	1.80	0.00	4.96	0.00
thalamus - adult, donor10196	10168-103B6	8.83	9.94	7.73	0.00	0.00	1.10	2.21	0.00
thalamus, adult, donor10252	10154-103A1	12.03	10.78	5.78	0.31	0.63	0.16	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	3.08	12.32	0.00	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	4.28	7.25	1.65	0.49	0.82	0.00	0.66	0.00
thalamus, newborn, donor10223	10366-105F6	12.08	5.75	9.78	0.00	0.58	0.00	0.00	0.00
throat, adult	10209-103G2	100.87	21.22	14.48	6.49	0.75	0.25	0.50	0.00
throat, fetal, donor1	10061-101H7	34.43	24.07	13.41	1.52	2.44	0.30	1.83	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	8.15	4.17	1.19	0.60	0.20	0.20	0.20	0.00
thymus, adult, pool1	10027-101D9	140.18	31.51	184.71	5.37	5.47	1.49	1.69	3.58
thymus, fetal, pool1	10043-101F7	115.13	29.92	160.53	5.20	4.47	1.04	1.04	1.97
thyroid carcinoma cell line:KHM-5M	10776-110G2	38.96	8.91	3.19	0.93	0.27	0.66	0.53	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	15.37	11.87	1.82	0.70	0.84	0.28	0.28	0.00
thyroid, adult, pool1	10028-101E1	55.33	22.95	15.96	3.64	1.68	0.09	0.75	0.00
thyroid, fetal, donor1	10060-101H6	35.59	19.25	11.86	1.05	1.58	0.00	2.11	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	15.40	6.16	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	43.96	12.09	3.72	0.70	0.70	0.00	1.63	0.00
tongue, fetal, donor1	10059-101H5	49.26	24.04	10.25	3.55	1.58	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	34.06	8.82	4.41	1.10	0.70	0.20	0.10	0.10
trachea, adult, pool1	10029-101E2	135.87	34.36	14.31	6.38	1.47	0.33	0.98	0.57
trachea, fetal, donor1	10058-101H4	88.10	26.93	26.16	6.16	2.69	0.38	2.31	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	52.79	19.49	5.31	1.42	0.35	1.06	3.90	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	45.19	11.14	2.33	1.93	0.20	0.41	0.00	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	52.18	11.59	11.91	2.35	0.63	0.47	0.94	0.31
tridermal teratoma cell line:HGRT	10694-109G1	32.34	3.81	3.81	0.00	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	15.91	9.23	6.35	1.61	0.42	0.08	0.42	0.00
umbilical cord, fetal, donor1	10057-101H3	8.35	27.12	8.35	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	21.16	9.21	3.92	0.34	0.34	0.17	0.68	0.00
uterus, fetal, donor1	10055-101H1	25.60	17.92	15.36	0.00	2.05	0.00	1.02	0.00
vagina, adult	10204-103F6	10.34	7.75	5.17	0.00	0.00	0.00	0.65	0.00
vein, adult	10191-103E2	21.26	6.36	17.54	0.00	1.10	0.22	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	2.14	4.81	0.80	0.27	0.00	0.00	0.00	0.00